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ABSTRACT 
Synthesis and Tracking of Fluorescent and Polymerization-
Propelled Single-Molecule Nanomachines 
by 
Jazmin Godoy Vargas 
This dissertation describes the synthesis of molecular machines designed to 
operate on surfaces (nanocars) or in the solution phase (nanosubmarines), and the 
study of their diffusion using fluorescence techniques. The design of these molecular 
machines is aimed to facilitate monitoring of their movement and incorporation of a 
source of energy for propulsion.    
To complement previous scanning tunneling microscopy studies of the 
translation of nanocars on surfaces, chapter 1 describes the synthesis of a family of 
fluorescently tagged nanocars. The nanocars were functionalized with a 
tetramethylrhodamine isothiocyanate (TRITC) fluorescent dye. Single-molecule 
fluorescence microscopy (SMFM) studies of one of these nanocars revealed that 
25% of the nanocars moved on glass. The SMFM results also suggested that the dye 
hindered the mobility of the nanocars.   
Seeking to improve the mobility, chapter 2 presents the synthesis of a new 
set of fluorescent nanocars, featuring a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
(BODIPY) dye embedded in their axles. The mobility of these inherently fluorescent 
nanocars on glass was nearly double than that of their TRITC-tagged predecessors. 
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Their diffusion was also studied on reactive-ion-etched glass, and amino-
functionalized glass. The results showed that the mobility is affected by the 
substrate. 
To equip the nanocars with an energy input for propulsion, two nanocars 
functionalized with an olefin metathesis catalyst were synthesized, as described in 
chapter 3. The catalytic activity of these nanocars toward ring-opening metathesis 
polymerization (ROMP) in solution was similar to that of their parent catalysts.  
As an alternative approach to investigate if chemical propulsion through a 
ROMP process can be achieved at the molecular level, chapter 4 presents the 
synthesis of a fluorescent ROMP catalyst, termed a nanosubmarine, and the study of 
its diffusion using fluorescence correlation spectroscopy (FCS). FCS results showed 
an increase of 20 ± 7% in the diffusion constant of this nanosubmarine in presence 
of its fuel, cis,cis-1,5-cyclooctadiene. 
Overall, the work accomplished in this dissertation constitutes a step 
forward toward development of easily tracked and highly mobile nanocars, and 
paves the way for the synthesis of truly nanosized chemically propelled molecular 
machines that operate in the solution phase. 
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Chapter 1 
Synthesis of Fluorescent Dye-Tagged 
Nanocars    
Note: This chapter was copied in its total from a paper that I coauthored.1 Reprinted with 
permission from reference 1. Copyright 2010 American Chemical Society. Some updated 
references were added, however.  
1.1.  Introduction 
The construction of nanomachines that exhibit controlled movements in solution2 
have lead researchers to explore the design, synthesis and manipulation of more complex, 
highly functional devices that can be studied not only as ensembles, but as single entities.3 
Adapting the approach taken by biological systems, synthetic strategies often arrive at 
these structures via bottom-up construction, quickly generating nanometer-sized 
configurations from the most basic organic building blocks.4 Concomitantly, the 
development of increasingly powerful imaging tools has enabled the study of the individual 
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rotational, translational and transportation dynamics of biological5 and synthetic6 
nanomachines on surfaces.  
Though interesting results have been obtained using other methods, 6b,6c scanning 
tunneling microscopy (STM) remains unparalleled in its ability to resolve molecular-sized 
structures and to track the translational movement of nanoscale objects.7 To this end, 
various groups have synthesized molecular motors and rotors,8 landers,9 wheel barrows,10 
nanowalkers,11 and polyaromatic systems12 for the purpose of observing their behavior on 
metallic surfaces. Similarly, our group has combined various nanocomponentry with 
molecular axles containing fullerene, p-carborane or organometallic wheels to construct a 
number of nanovehicles designed for directed motion and transport along atomically flat 
surfaces.4a,13 Proof-of-concept experiments have shown, using STM, the directed movement 
of fullerene-wheeled nanocars on atomically flat Au(111) surfaces upon thermal and 
electrogradient activation.14  
Although STM remains invaluable in the study of atomic detail and mechanism, the 
experimental conditions required are often less than ideal. The STM measurements are 
time consuming, conductive substrate surfaces must be used, and cryogenic and high-
vacuum settings are often required to obtain clean images.6b,15 Single-molecule 
fluorescence microscopy (SMFM), which has been widely used to track motion in biological 
systems,16 offers a complementary technique to STM to study single molecules but on 
nonconductive surfaces. While SMFM does not have the atomic resolution of STM, 
nanometer localization is possible with large photon count rates, and fast measurement of 
distances as low as several nanometers has been realized on larger scan areas.16,17  
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To obtain accurate measurements of single molecules, it is of paramount importance 
to ensure that a) the molecules of interest fluoresce well and b) fluorescence from 
impurities, optics, and substrate surfaces is avoided.18 Molecular design ensures that the 
first requirement is achieved, while the other is typically met by using excitation light with 
wavelengths greater than 500 nm since fewer molecules and substrates absorb in this 
region.19 In our case, use of such light came with a caveat, as our previously synthesized p-
carborane nanocars20 do not possess absorption bands in this region. In general, molecules 
are tagged with a high-quantum-yield fluorescent dye to enable visualization at longer 
wavelengths. For our purposes, tetramethylrhodamine isothiocyanate (TRITC) was an 
attractive dye, as it possesses an excitation wavelength centered at the emission line of our 
Nd:Vanadate laser (532 nm), good quantum yield of fluorescence, and is appended to 
molecular structures via a simple urea formation by reaction with amines.21 The 
attachment of TRITC to nanovehicular structures should afford the ability to more easily 
study the behavior of nanocars on nonconductive surfaces where ultra-high vacuum is not 
required.  
In an effort to elucidate the mechanism of movement and control the directionality 
of nanovehicles via specific arrangements of their molecular axles and wheels, reported 
here are the syntheses and optical properties of five fluorescently tagged nanovehicles 
(Figure 1.1) specifically designed for SMFM. The molecules all bear TRITC fluorescent tags 
for excitation at 532 nm and p-carborane wheels. The main reasons for choosing p-
carborane were 2-fold: (1) its ability to be substituted at both carbon atoms para to one 
another and (2) its stability towards many organometallic and photoinitiated processes. 
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As shown in Figure 1.1, nanocars 1 and 2 were designed to move along a straight 
trajectory due to the placement of the axles parallel to one another. Nanocar 3 was 
designed to move in a circular motion, a result of the axles angled towards each other. 
Analogous to our previous work with fullerene nanomachines, trimer 4 was designed to 
exhibit a pivoting motion, assessable by polarization experiments, with no translation. Due 
to the initial results from imaging trimer 4,22 nanocar 5 was designed to ascertain the effect 
of TRITC on wheel rotation and nanocar movement.  
5 
 
 
 
 
Figure 1.1.1 The structures of the TRITC-tagged nanovehicles and their expected 
directional motion.  Every vertex of the carborane wheel is BH except the darkened sites, 
where the outer (para) is CH and the inner (ipso) is an alkynyl-substituted C. Only the 5-
isomer adduct of TRITC is shown.  
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1.2. Results and Discussion 
1.2.1. Design and Synthesis 
The strategy to arrive at each target adopted a convergent approach, where the 
inner components of each nanovehicle were synthesized and then attached to versatile p-
carborane-containing axles. The design of nanocars 1, 2, and 3 dictated the use of two 
different molecular axles, with one axle bearing a pendant aniline for the attachment to 
amine-reactive TRITC. To arrive at trimer 4 and nanocar 5, we used a convergent, 
symmetric approach to synthesize a late-stage intermediate, followed by statistical 
attachment of an extended aniline to one wheel for the purpose of TRITC tagging. 
As depicted in Scheme 1.1, the synthesis of nanocar 1 began with the coupling of 
iodide axle 623 to the methoxy-containing inner chassis 724 using conventional Sonogashira 
conditions followed by deprotection to yield the terminal alkyne 8. Immediate coupling 
with known aniline axle 924 was performed to give the aniline nanocar 10. In a final step, 
the aniline group of 10 was reacted with TRITC in DMF at elevated temperature, with 
triethylamine as base, to give target nanocar 1 in 16% yield. It is possible that the low yield 
was a result of steric bulk around the reacting aniline. 
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Scheme 1.1.1 Synthesis of TRITC-tagged nanocar 1. 
 
SMFM results showed that the axle-tagged nanocar 1 has sufficient energy at room 
temperature to move along a glass surface at high rates of displacement.22 This was an 
encouraging result, as the attachment of a relatively large fluorescent tag to the central 
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aromatic moiety of the axle of nanocar 1 demonstrated that transport on the nanoscale is 
not impeded by the TRITC.  
The proposed mechanism22 suggests that increasing the number of wheels (thereby 
increasing the surface interaction) should lead to a more controlled motion over a larger 
distance, with the possibility that the increase in the number of wheels would produce a 
concomitant decrease in the speed of the movement. 
In an effort to improve controlled straight-line directionality via increased surface 
interaction, we synthesized an extended-chassis tagged nanovehicle with three axles and 
six wheels. 
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Scheme 1.2.1 Synthesis of TRITC-tagged six-wheeled nanovehicle 2. 
 
As shown in Scheme 1.2, the synthesis was carried out beginning with an 
intermediate similar to that used for the synthesis of the four-wheeled tagged nanocar. 
After two straightforward steps, the half-nanocar was once again deprotected to give 12. 
Separately, 1,4-diiodo-2,5-bis(trimethylsilylethynyl)benzene (13)20 was subjected to 
desilyl bromination. The resultant alkynyl bromide 14 was coupled with p-carborane (15) 
via a carborane-copper adduct to give diiodide axle 16. A statistical coupling between axle 
16 and 12 gave the four-wheeled iodide nanocar 17. It should be noted that in order to 
increase the solubility of the six-wheeled nanocar, the methoxy groups were replaced by 
more solubilizing propoxy groups. The extended aniline axle 20 was obtained in three 
steps starting with a statistical Sonogashira coupling between axle 16 and 4-ethynylaniline 
(18).25 Subsequently, 19 was coupled to the chassis 1126 followed by deprotection to yield 
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the extended aniline axle with chassis 20. A final Sonogashira coupling to four-wheeled 
iodo-nanocar 17 gave the six-wheeled extended aniline nanocar 21 in 45% yield. The use 
of the Fu-modified Sonogashira method27 with the air-stable HP(tert-Bu)3BF4 proved to be 
exceedingly effective since conventional conditions using triphenylphosphine afford only a 
18% yield. Room temperature attachment of the aniline to TRITC was then carried out 
again in DMF with triethylamine to provide the target six-wheeled tagged nanovehicle 2. 
 Scheme 1.3.1 Synthesis of TRITC-tagged angled nanocar 3. 
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While changing molecular design by increasing the number of axles and wheels 
should be a way to improve straight-line trajectory over longer distances, we also aimed to 
control the directionality by varying the angles of attachment to carborane-wheeled 
molecular components. Thus, we synthesized a nanocar with a bent chassis structure, 
designed to produce a circling motion (Scheme 1.3), by using a differentially substituted 
carbazole as the angling unit and a combination of iodide axle 6 and aniline axle 9, the later 
being for the TRITC attachment. Although the expected circumference of the circle traveled 
by nanocar 3 would be smaller than the detection limit of our current SMFS setup, 
polarization anisotropy measurements have given very accurate rotational measurements, 
as demonstrated by previous studies on biological motors and our initial SMFS studies.16,22 
Therefore 3 was synthesized initially through two consecutive Sonogashira reactions that 
were carried out on the diiodocarbazole 22.28 The first coupling used 0.6 equiv of 
trimethylsilylacetylene (TMSA) to yield 23. The coupling that followed, making use of the 
more robust triisopropylsilylacetylene (TIPSA), gave, after selective TMS deprotection, 24 
in a combined yield of 75%. Alkyne 24 was further coupled to aniline axle 9 to give, after 
deprotection, the half-angled nanocar 25. A further coupling with the iodo axle 6 gave the 
angled aniline nanocar 26, that was then reacted with TRITC to give the tagged angled 
nanocar 3 in 13% yield. Again, the final TRITC coupling was the lowest yielding step of the 
sequence. 
To further explore our ability to study directionality and molecular behavior, trimer 
4 was designed and synthesized to have analogous properties to those of a previously 
studied fullerene-wheeled trimer, where the molecule undergoes no translation, but 
rotates about the central trialkynylated benzene.14 
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 Scheme 1.4.1 Synthesis of trimer 4. 
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To synthesize trimer 4 (Scheme 1.4), we first attempted to use an early-stage 
statistical coupling to 1,3,5-tribromobenzene, followed by the coupling of a fully elaborated 
pendant aniline arm to the benzene core. This method, however, proved to be lengthy and 
low yielding. Using a late-stage statistical approach, trimer 4 was convergently constructed 
in four synthetic steps, where 1,3,5-triethynylbenzene 2720 was coupled to 3 equiv of 
known carborane arm 2820 to give the symmetrical trimer 29 in good yield. Initially, 
statistical attachment of the p-(bromoethynyl)nitrobenzene (30) unit was carried out 
under standard conditions for unsubstituted p-carborane functionalization: 29 was 
deprotonated using 1 equiv of n-butyllithium at −78 °C, followed by equilibration at room 
temperature for 30 min, then cooled again to −78 °C. Transmetalation was then performed 
by addition of CuBr and allowing the mixture to warm to room temperature, followed by 
coupling with the alkynyl bromide. Unfortunately, no product was obtained using this 
protocol and the starting material was almost totally recovered. In monosubstituted p-
carboranes, Fox and co-workers have reported an influence of the substituent on the 
unsubstituted carbon.29 Substitutions by electron-donating groups increase electron 
density on the para-carbon, following a Hammet p plot with good correlation. Hence, 
modification of the procedure by lowering the temperature of the equilibration steps to 
−15 °C and increasing the equilibration times to 1 h led to formation of p-
(bromoethynyl)nitrobenzene-substituted trimer 31 in 22% yield. The pendant nitro was 
then smoothly reduced using zinc powder and acetic acid in THF to provide the aniline 32 
in quantitative yield. Reaction with TRITC provided fluorescently tagged trimer 4. It should 
be noted that these less hindered aniline-TRITC coupling yields were considerably higher 
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than in the hindered aniline cases. Hence, a steric retardation on the coupling was likely the 
cause of the much lower yields of the nanocars 1 and 3. 
SMFM imaging of TRITC-tagged trimer 4 showed that the molecule is stationary, 
exhibiting no translational motion. While a lack of translational motion was expected, the 
molecule also failed to show any rotational movement by polarization anisotropy 
measurements.22 This lack of rotation could be due to molecular design, where TRITC is 
attached via a pendant group emanating from one wheel, causing it to act as a brake.  
 Scheme 1.5.1 Synthesis of wheel-tagged nanocar 5. 
 
To test this hypothesis, we synthesized a wheel-tagged fluorescent nanocar (Scheme 
1.5). Known nanocooper 3320 was subjected to statistical carborane substitution 
conditions, similar to those developed for the synthesis of the trimer, resulting in a 16% 
yield of 34 and 34’; a lower yield when compared to the trimer 4 due to the statistical 
contribution of one extra wheel. The substitution of only one of the four wheels of nanocar 
33 leads to two regioisomers, corresponding to substitution on the ortho- or meta-
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positioned ethynyl carborane relative to the inner chassis. The two isomers are obtained as 
a 1:1 mixture that is inseparable by column chromatography. The current mechanism of 
translocation suggests that the two isomers should exhibit similar behavior on the glass 
surface, so the mixture was carried on through the rest of the synthetic sequence. 
Subsequent reduction to anilines 35 and 35’ and TRITC attachment gave wheel-tagged 
nanocars 5 and 5’ in a combined 29% yield. Initial SMFM results indicate that TRITC may 
indeed act as a brake, as only 5% of the nanocars exhibited translational motion, compared 
to 25% for nanocar 1. 
1.2.2. Optical Properties 
We recently reported upon the solution-based ensemble absorption and 
fluorescence spectroscopy measurements of carborane-containing conjugated molecules.20  
 
Figure 1.2.1 UV−vis spectra of aniline substituted nanocars in CHCl3.  
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As shown in Figure 1.2, the aniline precursors show two absorption maxima; the 
first one in the region max = 288−294 and the second around 400 nm. A trend can be noted 
in the relative absorption energies of the alkoxy-functionalized nanovehicles, where 
increasing conjugation length (and the corresponding number of alkoxy units) causes a 
decrease in the HOMO−LUMO gap, red-shifting the max values in the order 21 > 10  35 > 
26 > 32. Despite the fact that the aniline precursors show relatively high quantum yield 
(Table 1.1), we are unable to use them in SMFM measurements, as none of these molecules 
can be excited at 532 nm, which our current setup requires.22  
 
Figure 1.3.1 UV−vis spectra of 1 − 5 in CHCl3.  
 
Although much synthetic effort is required to attach TRITC to our molecules, of 
paramount importance for the detection of single fluorescent molecules is the elimination 
of background fluorescence, in particular, fluorescence from luminescent impurities and 
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optical and substrate surfaces. Therefore, by using a fluorescent dye with > 500 nm 
wavelength excitation, we minimize undesired fluorescence, as fewer molecules and 
substrates are known to undergo absorption and emission in this region.19 
As shown in the absorption spectra in Figure 1.3, upon TRITC attachment, all of the 
nanovehicles exhibit an absorption peak centered between 532 and 552 nm while still 
maintaining a UV-blue profile near-identical to the main nanovehicle structure. The 
absence of any vibronic structure is a clear indication that the presence of TRITC does not 
disturb the molecules’ freedom of axle rotation in the ground state, a feature which is 
necessary for traversing sub-nanometer surface irregularities when related nanocars were 
studied on surfaces.30  
It is interesting to note that the non-tagged aniline precursors all exhibit 
fluorescence quantum yields higher than those of their TRITC-tagged cousins (Table 1.1) 
along with very large Stokes shifts, indicating that large geometric changes occur in their 
excited states. Nevertheless the TRITC tagged nanocars display suitable quantum yields for 
SMFM studies on a glass surface, thereby fulfilling the intent of this synthetic approach.  
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Compound 
Absorption maxima 
λmax, (ε (M-1, cm-1)) 
em  
(nm) 
ΦFa 
1 286 (18 700), 392 (6 000), 
540 (3 400) 
564 0.37 
2 286 (16 200), 406 (4 500), 
532 (900) 
554 0.22 
3 286 (8 100), 546 (3 000) 564 0.40 
4 312 (15 800), 362 (11 000), 
552 (9 700) 
569 0.47 
5 288 (11 500), 380 (2300), 
532 (1 200) 
560 0.23 
8 288 (73 800), 382 (24 600) 436 0.75 
17 284 (25 000), 429 (17 800) 471 0.22 
21 290 (97 000), 364 (33 100) 438 0.33 
27 294 (92 000), 366 (86 100) 400 0.67 
30 288 (102 200), 386 (21 800) 428 0.65 
 
Table 1.1.1 Optical properties of key compounds. aDetermined in chloroform solution, ca. 1 
 10−7 M. Using rhodamine 6G as reference, ΦF = 0.95 in EtOH, exc = 488 nm. Excitation 
was done at the corresponding max − 30 nm for compounds 1-5. For other compounds 
excitation was done at max.  
1.3. Conclusions 
The design and synthesis of five fluorescently tagged nanovehicles for the purpose 
of SMFM imaging is reported. The attachment of the TRITC fluorescent dye label to the 
nanovehicles was accomplished through the coupling of the isothiocyanate residue of the 
fluorophore with an aniline-functionalized nanovehicle. Several arrangements of axles on 
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the chassis were used to achieve different directional motion on the surface. Optical studies 
revealed that tagging with a TRITC moiety renders the nanocars suitable for SMFM studies 
with excitation at 532 nm. 
1.4. Experimental Section 
General Methods. 1H NMR and 13C NMR spectra were recorded at 400 or 500 and 
100 or 125 MHz, respectively. Proton chemical shifts () are reported in ppm downfield 
from tetramethylsilane (TMS).  All MALDI-TOF experiments were performed using α-
cyano-4-hydroxy-cinnamic acid as the matrix. FTIR spectra were recorded by deposition of 
the sample on a KBr plate from a CH2Cl2 solution using a Nicolet FTIR Infrared Microscope 
with ATR objective with 2 cm−1 slit. All reactions were performed under an atmosphere of 
nitrogen unless stated otherwise. Reagent grade tetrahydrofuran (THF) was distilled from 
sodium benzophenone ketyl. Triethylamine (TEA) and CH2Cl2 were distilled over CaH2. 
CuBr was purified by suspension in hot MeOH and filtration. Trimethylsilylacetylene 
(TMSA) was donated by FAR Research Inc. or Petra Research. All other chemicals were 
purchased from commercial suppliers and used without further purification. Flash column 
chromatography was performed using 230−400 mesh silica gel from EM Science. Thin layer 
chromatography was performed using glass plates pre-coated with silica gel 40 F254 
purchased from EM Science. The syntheses of compounds 6,23 7,24 9,24 11,26 13,20 18,25 
22,28 27,20 28,20 and 3320 were performed according to formerly reported protocols. 
General Procedure for the Coupling of a Terminal Alkyne with an Aryl Halide 
Using a Palladium-Catalyzed Cross-Coupling (Sonogashira) Protocol. To an oven-dried 
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round-bottom flask equipped with a magnetic stir bar were added the aryl halide, the 
terminal alkyne, PdCl2(PPh3)2 (ca. 2 mol % per aryl halide), and CuI (ca. 4 mol % per aryl 
halide). A solvent system of TEA and/or THF was added depending on the substrates. Upon 
completion, the reaction was quenched with a saturated solution of NH4Cl. The organic 
layer was then diluted with hexanes, diethyl ether or CH2Cl2, and washed with water or 
saturated NH4Cl (1). The combined aqueous layers were extracted with hexanes, diethyl 
ether, or CH2Cl2 (2). The combined organic layers were dried over MgSO4 and filtered, and 
the solvent was removed from the filtrate in vacuo to afford the crude product, which was 
purified by column chromatography (silica gel). Eluents and other slight modifications are 
described below for each compound. 
General Procedure for Deprotection of TIPS-Protected Alkynes using TBAF. In 
a round-bottom flask equipped with a magnetic stir bar, the protected alkyne was 
dissolved in THF or CH2Cl2 ([protected alkyne] = 0.05 − 0.1 M). TBAF in THF (1.0 M, 1.1 
equiv per alkyne) was added. The mixture was stirred at rt for 0.5 h or until the reaction 
was complete (monitored by TLC). Silica gel was added and the solvent was removed in 
vacuo. The resulting product loaded onto silica gel was then purified by column 
chromatography (silica gel as the stationary phase) to provide the product. 
Compound 8. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were 623 (0.150 g, 0.28 mmol), 724 (0.091 g, 0.27 mmol), PdCl2(PPh3)2 
(0.020 g, 0.028 mmol), CuI (0.012 g, 0.063 mmol), TEA (0.32 mL), and THF (4.0 mL) at rt 
overnight. The residue was purified by flash column chromatography in silica gel using 
20% CH2Cl2 in hexanes; the product-containing fractions were combined, concentrated and 
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the residue was subjected to the general procedure for the deprotection of TIPS-protected 
alkynes. The materials used were the TIPS protected intermediate (0.090 g, 0.12 mmol), 
TBAF (0.20 mL, 1.0 M in THF) and CH2Cl2 (3 mL). The mixture was stirred at rt for 0.5 h, 
then passed through a silica plug using 30% CH2Cl2 in hexanes as eluent to yield 8 (0.071 g, 
45%, two steps) as an off-white solid. FTIR (KBr) 2926, 2615, 1502, 1463, 1408, 1385, 
1221, 1064, 1041, 785, 665 cm−1; 1H NMR (400 MHz, CDCl3)  7.45 (d, J = 1.2 Hz, 1H), 7.22 
(d, J = 8.0 Hz, 1H), 7.13 (dd, J1 = 8.0 Hz, J2 = 1.2 Hz, 1H), 7.04 (s, 1H), 7.01 (s, 1H), 3.97 (s, 
3H), 3.89 (s, 3H), 3.44 (s, 1H), 3.40−1.45 (br m, 22H); 13C NMR (100 MHz, CDCl3)  154.5, 
154.0, 135.3, 132.1, 131.0, 126.4, 123.8, 122.0, 116.2, 115.6, 113.4, 112.5, 91.8, 91.0, 90.4, 
87.8, 82.8, 79.9, 77.9, 77.7, 60.3, 56.5, 56.4; EI-HRMS m/z calcd for C26H34B20O2 595.4549, 
found 595.4552. 
Compound 10. Terminal alkyne 8 (0.019 g, 0.031 mmol) was subjected to the 
general Sonogashira protocol, using 924 (0.019 g, 0.034 mmol), PdCl2(PPh3)2 (0.002 g, 0.003 
mmol), CuI (0.001 g, 0.006 mmol), TEA (1 mL), and THF (5 mL) and stirred at rt overnight. 
The resulting residue was purified by column chromatography in silica gel with 25% 
CH2Cl2 in hexanes to give product 10 (0.017 g, 53%) as a light yellow solid. FTIR (neat) 
3493, 3395, 3061, 2924, 2853, 2614, 2358, 2205, 1615, 1507, 1220, 1063, 727 cm−1; 1H 
NMR (400 MHz, CDCl3) δ 7.47 (d, J = 1.5 Hz, 1H), 7.33 (s, 1H), 7.22 (d, J = 8 Hz, 1H), 7.13 (dd, 
J1 = 8 Hz, J2 = 1.5 Hz, 1H), 7.04 (s, 2H), 6.59 (s, 1H), 4.13 (br s, 2H), 3.98 (s, 6H), 2.6 (br m, 
44H); 13C NMR (100 MHz, CDCl3) δ 154.0, 153.7, 147.4, 136.1, 135.3, 132.1, 130.8, 126.6, 
125.1, 123.7, 121.9, 117.2, 115.5, 115.4, 115.3, 114.1, 112.2, 106.6, 92.7, 92.6, 91.6, 90.94, 
90.91, 87.7, 77.9, 77.8, 74.8, 60.2, 56.3, 29.6; MALDI-TOF MS (+eV) m/z calcd for 
C40H59B40NO2 1018.9, found 1019.0. 
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Nanocar 1. In a Schlenk tube under nitrogen, 10 (0.021 g, 0.026 mmol) was 
dissolved in DMF (1.0 mL) and Et3N (0.1 mL). TRITC (5.8 mg, 0.013 mmol) in solution in 
DMF (1.0 mL) was added dropwise, and the mixture was heated to 60 °C, then stirred 
overnight in the dark.  The solvents were then removed by rotary evaporation under 
reduced pressure. The resulting solid was purified by flash column chromatography in 
silica gel with 10% MeOH in CH2Cl2 to yield 1 as a purple solid (3 mg, 16%). FTIR (neat) 
3349, 2960, 2921, 2851, 2615, 2359, 2342, 1737, 1596, 1510, 1249, 1185, 1112, 1039, 828, 
803 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.98 (br s, 1H), 7.82 (d, J = 8.8 Hz, 1H), 7.48 (m, 1H), 
7.15 (m, 6H), 6.82 (m, 2H), 6.69 (d, J = 8.6 Hz, 2H), 6.50 (d, J = 2.0 Hz, 2H), 6.42 (dd, J1 = 7.6 
Hz, J2 = 2.0 Hz, 2H), 4.01 (s, 6H), 3.00 (s, 12H), 3.00−1.47 (br m, 44H). The material was not 
soluble enough for 13C analysis. MALDI-TOF MS (+eV) m/z calcd 1461.9, found 1462.2. 
Compound 12. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 6 (60 mg, 0.12 mmol), 1126 (53 mg, 0.13 mmol), 
PdCl2(PPh3)2 (10 mg, 0.01 mmol), CuI (5.0 mg, 0.02 mmol), THF (10 mL), and Et3N (5 mL) 
at rt overnight. The crude product was purified by column chromatography (silica gel, 10% 
CH2Cl2 in hexanes) to yield a white solid (70 mg). The product was then deprotected (see 
the general procedure for the removal of TMS/TIPS protecting groups). The materials used 
were the white solid (70 mg, 0.086 mmol), THF (10 mL), and TBAF (0.40 mL, 0.40 mmol) at 
rt. The resulting reaction mixture was passed through a plug of silica gel, and concentrated 
to afford the title compound 12 as a yellow solid (56 mg, 77%, two steps). FTIR (KBr) 2925, 
2614, 1502, 1463, 1408, 1385, 1221, 1064, 1041, 785 cm−1; 1H NMR (500 MHz, CDCl3) δ 
7.38 (d, J = 1.6 Hz, 1H), 7.21 (d, J = 8.2 Hz, 1H), 7.12 (dd, J1 = 8.2 Hz, J2 = 1.6 Hz, 1H), 7.02 (s, 
1H), 6.99 (s, 1H), 4.06 (t, J = 6.5 Hz, 2H), 3.97 (t, J = 6.5 Hz, 2H), 3.37 (s, 1H), 3.00−1.60 (br 
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m, 26H), 1.09 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 154.2, 153.7, 135.4, 132.3, 131.0, 126.9, 
123.8, 122.1, 118.0, 117.0, 114.2, 113.3, 91.8, 91.1, 91.0, 88.0, 82.7, 80.1, 78.1, 77.9, 71.25, 
71.22, 69.6, 60.4, 22.85, 22.83, 18.3, 18.0, 17.9, 12.7, 12.5, 10.7, 10.6; EI-HRMS calcd for 
C30H42B20O2 650.5191, found 650.5163. 
Compound 14. A 25 mL round-bottom flask equipped with a magnetic stir bar was 
charged with 1320 (320 mg, 0.61 mmol) and acetone (10 mL). Then N-bromosuccinimide 
(229 mg, 1.28 mmol) and AgNO3 (20 mg, 0.12 mmol) were added, in that order. The 
mixture was stirred in the dark at rt for 2 h, and then the solvent was removed in vacuum. 
The residue was passed through a silica gel plug using CH2Cl2 followed by Et2O as eluents, 
to give 14 as a white solid (300 mg, 92%). Caution: alkynyl bromides decompose over time 
and evolve HBr. Care should be taken when handling. FTIR (neat) 3072, 2998, 2952, 2919, 
2849, 1760, 1453, 1325, 1242 cm−1; 1H NMR (400 MHz, CDCl3)  7.84 (s, 2H); 13C NMR (100 
MHz, CDCl3)  142.4, 131.0, 99.1, 80.6, 58.1; EI-HRMS m/z calcd for C10H2Br2I2 533.6613, 
found 533.6606. 
Compound 16. An oven-dried 50 mL round-bottom flask equipped with a magnetic 
stir bar was charged with p-carborane (15) (85 mg, 0.59 mmol) and dry THF (8 mL). The 
solution was cooled to −78 °C and BuLi (0.24 mL, 0.60 mmol, 2.5 M in hexanes) was added 
dropwise. The solution was allowed to warm to room temperature and stirred for 30 min 
before it was cooled again at −78 °C. CuBr (121 mg, 0.84 mmol) was then added and the 
mixture was allowed to stir at rt for 30 min. A solution of 14 (150 mg, 0.28 mmol) in dry 
THF (10 mL) was added and the resulting mixture was allowed to stir overnight at rt. A few 
drops of water were added, and the mixture was filtered through a silica gel pad using 
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hexanes as the eluent. The resulting greenish solid was purified by column 
chromatography (silica gel, hexanes as eluent) to provide 16 (130 mg, 70%) as a white 
powder. FTIR (neat) 2613, 1463, 1384, 1123, 1084, 1064, 1047 cm−1; 1H NMR (400 MHz, 
CDCl3)  7.63 (s, 2H), 3.40−1.60 (br m, 22H); 13C NMR (100 MHz, CDCl3)  141.7, 129.9, 
99.7, 91.8, 79.8, 68.9, 61.0; EI-HRMS m/z calcd for C14H24B20I2 663.1949, found 663.1944. 
Compound 17. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 12 (58 mg, 0.09 mmol), 16 (98 mg, 0.15 mmol), 
PdCl2(PPh3)2 (10 mg, 0.01 mmol), CuI (5.0 mg, 0.02 mmol), THF (10 mL), and Et3N (5 mL) 
at rt overnight. The crude product was purified by column chromatography (silica gel, 
using 20% CH2Cl2 in hexanes) to yield 17 as a yellow solid (34 mg, 32%). FTIR (neat) 3060, 
2963, 2925, 2851, 2618, 2237, 2335, 2214, 1501, 1466, 1422, 1369, 1263, 1219, 1062 
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.74 (s, 1H), 7.40 (d, J = 1.6 Hz, 1H), 7.33 (s, 1H), 7.22 (d, J 
= 8.2 Hz, 1H), 7.14 (dd, J1 = 8.2 Hz, J2 = 1.6 Hz, 1H), 7.06 (s, 1H), 7.04 (s, 1H), 4.09 (t, J = 6.5 
Hz, 4H), 3.10−1.60 (br m, 48H), 1.13 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 153.94, 153.92, 
142.0, 135.5, 135.4, 132.3, 131.0, 128.7, 127.0, 126.6, 124.8, 123.9, 122.2, 117.02, 116.98, 
114.3, 113.7, 99.5, 92.4, 92.1, 91.9, 91.4, 91.2, 91.1, 88.0, 80.7, 78.2, 78.0, 77.4, 76.5, 71.22, 
71.19, 69.7, 69.3, 60.9, 60.7, 60.5, 53.6, 34.9, 29.9, 22.98, 22.96, 22.88, 10.78, 10.77; MALDI-
TOF MS (+eV) m/z calcd for C44H65B40IO2 1185.8, found 1186.0. 
Compound 19. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 16 (150 mg, 0.23 mmol), 4-ethynylaniline (18)25 (16 mg, 
0.13 mmol), PdCl2(PPh3)2 (157 mg, 0.224 mmol), CuI (85 mg, 0.45 mmol), THF (30 mL), 
and Et3N (10 mL) rt overnight. The crude product was purified by column chromatography 
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(silica gel, using 50% CH2Cl2 in hexanes) to yield 19 as a yellow solid (50 mg, 56%). 1H NMR 
(400 MHz CDCl3) δ 7.69 (s, 1H), 7.34 (d, J = 8.6 Hz, 2H), 7.32 (s, 1H), 6.66 (d, J = 8.6 Hz, 2H), 
3.89 (br s, 2H), 3.10−1.60 (br m, 24H); 13C NMR (100 MHz, CDCl3) δ 147.5, 141.9, 134.9, 
133.5, 128.4, 127.0, 124.6, 114.9, 111.9, 98.4, 97.0, 91.7, 90.9, 84.3, 80.9, 69.4, 60.7, 53.6, 
29.9; EI-HRMS calcd for C22H30B20IN 652.3418, found 652.3410. 
Compound 20. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 19 (30 mg, 46 µmol), 1126 (24 mg, 68 µmol), 
PdCl2(PPh3)2 (5 mg, 5 µmol), CuI (2.5 mg, 10 µmol), THF (10 mL), and Et3N (5 mL) at rt 
overnight. The crude product was purified by column chromatography (silica gel, hexanes / 
CH2Cl2 1:1) to yield a yellow solid (33 mg). The product was then deprotected (see the 
general procedure for the removal of TMS/TIPS protecting groups). The materials used 
were the white solid (33 mg, 35 µmol), THF (5 mL), and TBAF (0.10 mL, 0.10 mmol) at rt. 
The resulting reaction mixture was passed through a plug of silica gel, and concentrated to 
afford the title compound 20 as a yellow solid (26 mg, 75%, two steps). FTIR (neat) 3063, 
2960, 2927, 2863, 2612, 2356, 2338, 2326, 2200, 2167, 2150, 2041, 1979, 1717, 1605, 
1513, 1504, 1463, 1416, 1381, 1263, 1216, 1060 cm−1; 1H NMR (400 MHz CDCl3) δ 7.39 (s, 
1H), 7.37 (s, 1H), 7.35 (d, J = 8.6 Hz, 2H), 7.02 (s, 1H), 6.99 (s, 1H), 6.67 (d, J = 8.6 Hz, 2H), 
4.06 (d, J = 6.5 Hz, 2H), 3.97 (d, J = 6.5 Hz, 2H) 3.91 (br s, 2H), 3.38 (s, 1H), 3.10−1.60 (br m, 
26H), 1.09 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 154.3, 153.8, 135.8, 135.2, 133.6, 126.6, 
125.1, 123.7, 118.0, 117.0, 115.0, 114.2, 113.4, 112.0, 107.7, 92.0, 91.0, 85.0, 82.8, 80.2, 
71.3, 68.2, 60.6, 22.9, 18.4, 18.0, 10.7; MALDI-TOF MS (+eV) m/z calcd for C38H47B20NO2 
765.5, found 766.6 [M + H]. 
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Compound 21. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 17 (12 mg, 10 µmol), 20 (9 mg, 12 µmol), PdCl2(PhCN)2 
(2 mg, 5 µmol), (tert-Bu)3PHBF4 (4.5 mg, 15 µmol), CuI (1 mg, 5 µmol), THF (5 mL), and 
Et3N (2 mL) at 50 °C overnight. The crude product was purified by column chromatography 
(silica gel, using 50% CH2Cl2 in hexanes) to yield 21 as a fluorescent yellow solid (8.3 mg, 
45%). FTIR (neat) 2925, 2857, 2612, 2480, 2359, 2332, 1725, 1655, 1460, 1377, 1257, 
1066, 1036 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.42 (s, 2H), 7.40 (m, 3H), 7.36 (d, J = 8.6 Hz, 
2H), 7.23 (d, J = 8.2 Hz, 1H), 7.14 (dd, J1 = 8.2 Hz, J2 = 1.6 Hz, 1H), 7.07 (s, 1H), 7.06 (br s, 
3H), 6.68 (d, J = 8.6 Hz, 2H), 4.10 (t, J = 6.5 Hz, 8H), 3.91 (br s, 2H), 3.10−1.60 (br m, 74H), 
1.13 (m, 12H); 13C NMR (126 MHz, CDCl3) δ 154.0, 153.9, 153.9, 147.5, 135.8, 135.5, 135.2, 
133.6, 132.3, 127.0, 126.5, 125.9, 125.1, 123.9, 123.8, 123.7, 123.6, 122.2, 117.0, 114.9, 
114.2, 113.9, 112.0, 97.5, 92.9, 92.3, 92.2, 91.2, 91.1, 91.0, 85.1, 71.2, 69.6, 60.5, 59.1, 53.6, 
29.9, 23.3, 23.0, 22.9, 14.4, 14.3, 11.8, 10.8; MALDI-TOF MS (+eV) m/z calcd for 
C82H111B60NO4: 1822.5, found: 1823.6 [M + H]. 
Compound 2. In a Schlenk tube under nitrogen the aniline nanocar 21 (7 mg, 4 
µmol) was dissolved in CH2Cl2 (1.0 mL) and Et3N (0.1 mL). TRITC (1.7 mg, 4 µmol) in 
solution in DMF (1.0 mL) was added dropwise and the mixture stirred overnight at rt in the 
dark. The solvents were then removed by rotary evaporation under reduced pressure. The 
resulting solid was purified by column chromatography (silica gel, using 10% MeOH in 
CH2Cl2) to yield 2 as a purple solid (2.7 mg, 31%). FTIR (neat) 3349, 3193, 2919, 2851, 
2609, 2362, 2338, 2158, 1979, 1716, 1661, 1610, 1510, 1451, 1410, 1372, 1216, 1177, 
1104, 1062 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 2H), 7.66 (d, J = 9.1 Hz, 2H), 7.49 (d, J 
= 8.5 Hz, 1H), 7.47 (s, 1H), 7.09−7.03 (m, 5H), 6.99−6.97 (m, 2H), 6.69 (d, J = 8.9 Hz, 2H), 
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6.56−6.50 (m, 4H), 6.34−6.33 (m, 2H), 6.31 (d, J = 2.5 Hz, 1H), 6.02 (s 1H), 3.38 (t, J = 6.5 Hz, 
8H), 3.08 (br s, 12H), 3.00−1.47 (br m, 74H), 1.13 (m, 12H). The material was not soluble 
enough for 13C analysis. MALDI-TOF MS (+eV) m/z calcd for C107H132B60N4O7S 2266.9, 
found 2267.4. 
Compound 23. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were carbazole 2228 (3.54 g, 7.46 mmol), TMSA (0.64 mL, 4.48 
mmol), PdCl2(PPh)3 (157 mg, 0.22 mmol), CuI (85 mg, 0.45 mmol), THF (30 mL), and Et3N 
(10 mL) at rt overnight. The crude product was purified by column chromatography (silica 
gel, using 10% CH2Cl2 in hexanes) to yield 23 as a yellow solid (1096 mg, 55%). FTIR (neat) 
3204, 3060, 2960, 2930, 2869, 2353, 2323, 2153, 1858, 1628, 1590, 1478, 1434, 1384, 
1345, 1286, 1251, 1210, 1174, 1151, 1130, 1062, 1051, 1012, 897, 839, 803 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 8.34 (d, J = 1.7 Hz, 1H), 8.16 (d, J = 1.4 Hz, 1H), 7.69 (dd, J1 = 8.6 Hz, J2 = 
1.7 Hz, 1H), 7.57 (dd, J1 = 8.5 Hz, J2 = 1.6 Hz, 1H), 7.28 (d, J = 8.5 Hz, 1H), 7.16 (d, J = 8.6 Hz, 
1H), 4.22 (t, J = 8.0 Hz, 2H), 1.80 (quint, J = 7.5 Hz, 2H), 1.34 (sext, J = 7.5 Hz, 2H), 0.92 (t, J = 
7.4 Hz, 3H), 0.29 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 140.3, 140.1, 134.4, 130.4, 129.6, 
125.1, 124.9, 121.6, 113.9, 111.2, 108.9, 106.5, 92.3, 82.0, 43.2, 31.2, 20.7, 14.0, 0.4; EI-
HRMS m/z calcd for C21H24INSi 445.0717, found 445.0723. 
Compound 24. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were 23 (1.07 g, 2.4 mmol), TIPSA (1.1 mL, 4.95 mmol), PdCl2(PPh3)2 (84 
mg, 0.12 mmol), CuI (46 mg, 0.24 mmol), TEA (10 mL), and THF (30 mL) at rt overnight. 
The residue was purified by flash column chromatography in silica gel with 5% CH2Cl2 in 
hexanes; the product-containing fractions were combined and concentrated. The TMS-
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protected intermediate (983 mg, 1.97 mmol) was dissolved in 30 mL of a 1:1 mixture of 
THF and MeOH. Then K2CO3 (542 mg, 3.92 mmol) was added and the mixture was stirred at 
rt for 1.5 h. Then it was passed through a silica plug using 30% CH2Cl2 in hexanes as eluent 
to yield 24 (763 mg, 75%, 2 steps) as a yellow oil. FTIR (neat) 3311, 3042, 2954, 2942, 
2886, 2863, 2721, 2359, 2329, 2147, 2099, 1870, 1678, 1628, 1602, 1478, 1466, 1378, 
1351, 1289, 1251, 1213, 1151, 1133, 1068, 998, 918, 883, 803 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 8.23 (d, J = 1.2 Hz, 1H), 8.19 (d, J = 1.4 Hz, 1H), 7.60 (d, J = 1.5 Hz, 1H), 7.57 (d, J = 
1.5 Hz, 1H), 7.31 (d, J = 7.1 Hz, 1H), 7.29 (d, J = 7.1 Hz, 1H), 4.26 (t, J = 8.0 Hz, 2H), 3.06 (s, 
1H), 1.81 (quint, J = 8.0 Hz, 2H), 1.34 (sext, J = 8.0 Hz, 2H), 1.17 (s, 21 H), 0.92 (t, J = 8.0 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 140.6, 140.4, 130.2, 129.9, 124.8, 124.6, 122.3, 122.2, 
114.3, 112.6, 108.9, 108.8, 108.2, 88.3, 84.7, 75.3, 43.0, 31.0, 20.4, 18.7, 13.8, 11.4; EI-HRMS 
m/z calcd for C29H37NSi 427.2698, found 427.2695. 
Compound 25. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were 24 (30 mg, 69.6 µmol), 924 (32 mg, 58.0 µmol), PdCl2(PPh3)2 (6 mg, 8.7 
µmol), CuI (3.3 mg, 17.4 µmol), TEA (1 mL), and THF (3 mL) at rt overnight. The residue 
was purified by flash column chromatography in silica gel with 20% CH2Cl2 in hexanes; the 
product-containing fractions were combined and concentrated. The product was then 
deprotected (see the general procedure for the removal of TMS/TIPS protecting groups). 
The materials used were the yellow solid (38 mg, 44.0 µmol), THF (5 mL), and TBAF (0.33 
mL, 0.33 mmol) at rt. Then it was passed through a silica plug using 20% CH2Cl2 in hexanes 
as eluent to yield 25 (19.5 mg, 54%, 2 steps) as a yellow solid. FTIR (neat) 3487, 3393, 
3308, 3060, 2957, 2925, 2871, 2606, 2362, 2329, 2226, 2208, 2105, 1613, 1596, 1498, 
1478, 1381, 1357, 1286, 1210, 1151, 1127, 1062, 1006, 971, 886, 806, 753 cm−1; 1H NMR 
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(400 MHz, CDCl3) δ 8.28 (dd, J1 = 12.0 Hz, J2 = 4.0 Hz, 2H), 7.60 (dd, J1 = 12.0 Hz, J2 = 4.0 Hz, 
2H), 7.36 (t, J = 8.0 Hz, 2H), 7.31 (s, 1H), 6.61 (s, 1H), 4.30 (t, J = 8.0 Hz, 2H), 4.09 (s, 2H), 
3.30–1.50 (br m, 25H), 1.42 (quart, J = 8.0 Hz, 2H), 0.96 (t, J = 8.0 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ147.2, 140.9, 140.6, 135.7, 130.2, 129.7, 125.3, 125.1, 124.4, 122.7, 122.6, 
117.6, 116.3, 114.3, 112.8, 109.1, 106.9, 92.9, 90.1, 85.6, 85.0, 78.4, 75.5, 75.2, 60.3, 43.1, 
31.3, 20.7, 14.0; MALDI-TOF MS (+eV) m/z calcd for C34H42B20N2 694.9, found 695.5. 
Compound 26. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 25 (60 mg, 86.0 µmol), 623 (42 mg, 78.0 µmol), 
PdCl2(PPh)3 (5.5 mg, 7.8 µmol), CuI (3.0 mg, 3.0 µmol), THF (4.5 mL), and Et3N (1.5 mL) at 
rt overnight. The crude product was purified by column chromatography (silica gel, using 
25% CH2Cl2 in hexanes) to yield 26 as a yellow solid (54 mg, 63%). FTIR (neat) 3493, 3390, 
3066, 3010, 2927, 2654, 2609, 2362, 2323, 2207, 2158, 1610, 1590, 1493, 1460, 1384, 
1351, 1286, 1239, 1210, 1148, 1127, 1062, 1004, 968, 877, 806 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 8.37 (dd, J1 = 12.0 Hz, J2 = 4.0 Hz, 2H), 7.66 (dd, J1 = 12.0 Hz, J2 = 1.7 Hz, 1H), 7.64 
(dd, J1 = 12.0 Hz, J2 = 4.0 Hz, 1H), 7.41 (m, 3H), 7.24 (s, 1H), 7.24 (d, J = 4.0 Hz, 1H), 7.11 (dd, 
J1 = 8.0 Hz, J2 = 4.0 Hz, 1H), 6.62 (s, 1H), 4.33 (t, J = 8.0 Hz, 2H), 4.08 (br s, 2H),  3.40−1.40 
(br m, 48H),  0.99 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 147.2, 141.0, 140.6, 135.6, 
134.8, 132.4, 130.4, 129.7, 129.5, 127.4, 125.3, 124.7, 123.9, 122.9, 122.8, 122.0, 117.6, 
116.4, 114.4, 113.4, 109.4, 109.2, 106.8, 96.5, 93.0, 92.8, 91.0, 90.1, 87.8, 85.6, 85.3, 78.4, 
78.3, 78.2, 75.2, 69.9, 69.4, 60.5, 43.4, 31.4, 29.9,  20.8, 14.3, 14.1; MALDI-TOF MS (+eV) m/z 
calcd for C48H66B40N2 1103.4, found 1104.0. 
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Compound 3. In a Schlenk tube under nitrogen, the aniline nanocar 26 (19 mg, 17.2 
µmol) was dissolved in CH2Cl2 (1.0 mL) and Et3N (0.1 mL).  TRITC (8 mg, 17.2 µmol) in 
solution in DMF (1.0 mL) was added dropwise and the mixture stirred overnight at 50 °C in 
the dark. The solvents were then removed under reduced pressure. The resulting solid was 
purified by column chromatography (silica gel, using 10% MeOH in CH2Cl2) to yield 3 as a 
purple solid (3.3 mg, 13%). Note: It was not possible to obtain a clean 1H NMR spectrum of 3 
where all expected signals were observable due to the small amount prepared; however, the 
presence of the desired compound was confirmed by MALDI MS. FTIR (neat) 3343, 3060, 
2925, 2854, 2618, 2356, 2338, 2209, 1711, 1596, 1493, 1463, 1410, 1348, 1266, 1216, 
1189, 1127, 1104, 1062, 930, 827 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.5 Hz, 1H), 
7.70 (dd, J1 = 6.0 Hz, J2 = 3.5 Hz, 2H),  7.53 (dd, J1 = 6.0 Hz, J2 = 3.5 Hz, 2H), 7.47 (s, 1H), 7.30 
(s, 2H), 7.22 (s, 2H), 7.12 (m, 5H), 7.05 (s, 1H), 6.80 (m, 3H), 6.73 (d, J = 8.5 Hz, 1H), 4.22 (m, 
2H), 3.35 (s, 12H). The material was not soluble enough for 13C analysis. MALDI-TOF MS 
(+eV) m/z calcd for C73H87B40N5O3S 1547.0, found 1548.2 [M + H]. 
Compound 29. Trialkyne 2720 (0.100 g, 0.667 mmol) was subjected to the general 
Sonogashira protocol using 2820 (0.978 g, 2.00 mmol), PdCl2(PPh3)2 (0.126 g, 0.179 mmol), 
CuI (0.066 g, 0.346 mmol), TEA (3.0 mL), and THF (10.0 mL) and the mixture was stirred at 
rt overnight. The resulting residue was purified by column chromatography with 25% 
CH2Cl2 in hexanes to give 29 (0.557 g, 68%) as a light yellow solid. FTIR (KBr) 2963, 2613, 
1579, 1502, 1423, 1218, 1061 cm−1; 1H NMR (400 MHz, CDCl3)  7.57 (s, 3H), 6.89 (s, 3H), 
6.76 (s, 3H), 3.92 (t, J = 5.2 Hz, 6H), 3.87 (t, J = 5.2 Hz, 6H), 3.15–1.90 (br m, 33H), 1.82 (m, 
12H), 1.08 (m, 18H); 13C NMR (100 MHz, CDCl3)  154.5, 153.7, 134.2, 124.3, 117.2, 117.1, 
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114.5, 112.5, 93.5, 91.0, 87.1, 76.2, 71.4, 71.1, 22.9, 22.8, 10.8, 10.7; MALDI-TOF MS (+eV) 
m/z calcd for C60H84B30O6 1226.0, found 1226.0. 
Compound 30. 1-Nitro-4-trimethylsilylethynylbenzene (2.19 g, 10.00 mmol) was 
combined with AgNO3 (0.340 g, 2.00 mmol), N-bromosuccinimide (1.80 g, 10.1 mmol) and 
acetone (100 mL). The mixture was stirred for 2 h at rt in the dark, and poured onto a pad 
of silica gel. The pad was then eluted with 40% CH2Cl2 in hexanes and the solvents removed 
to yield 30 (2.37 g, 91%) as a light yellow solid. Caution: alkynyl bromides decompose over 
time and evolve HBr. Care should be taken when handling. FTIR (KBr) 3105, 2196, 1772, 
1698, 1591, 1508, 1346, 1192, 853, 748 cm−1; 1H NMR (500 MHz, CDCl3)  8.18 (d, J = 8.8 
Hz, 2H), 7.58 (d, J = 8.8 Hz, 2H); 13C NMR (126 MHz, CDCl3)  147.5, 133.0, 129.7, 123.8, 
78.6, 56.6; EI-HRMS m/z calcd for C8H4BrNO2 224.9425, found 224.9419. 
Compound 31. Trimer 29 (0.40 g, 0.33 mmol) was added to an oven-dried, three-
neck round-bottom flask, followed by THF (5 mL). The mixture was cooled to −78 °C, and 
BuLi (2.5 M in hexanes, 0.13 mL, 0.033 mmol) was added dropwise. The mixture was 
allowed to stir at −15 °C for 1 h, followed by cooling to −78 °C. To the blue mixture was 
then added CuBr (0.061 g, 0.424 mmol), followed by warming to −15 °C and stirring for 1 h. 
Alkynyl bromide 30 (0.096 g, 0.424 mmol) was then added all at once as a solid, and the 
mixture was allowed to warm to rt and stirred overnight. The reaction was quenched by 
addition of 1 drop of water, followed by elution through a Celite pad with CH2Cl2. The 
resulting residue was then purified using flash chromatography with 25% CH2Cl2 in 
hexanes as eluent to give product 31 (0.098 g, 22%) as a light yellow solid. FTIR (KBr) 
2963, 2925, 2875, 2855, 2615, 1579, 1502, 1467, 1423, 1387, 1343, 1276, 1218, 1062, 
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1017, 989 cm−1; 1H NMR (400 MHz, CDCl3)  8.14 (d, J = 7.2 Hz, 2H), 7.57 (s, 3H), 7.47 (d, J = 
6.8 Hz, 2H), 6.89 (s, 3H), 6.76 (s, 3H), 3.92 (t, J = 5.2 Hz, 6H), 3.86 (t, J = 5.2 Hz, 6H), 3.20–
1.90 (br m, 33H), 1.81 (m, 12H), 1.07 (m, 18H); 13C NMR (100 MHz, CDCl3)  154.5, 153.7, 
147.8, 134.2, 133.1, 128.2, 124.3, 124.2, 123.7, 117.19, 117.17, 117.1, 117.0, 114.8, 114.5, 
93.7, 93.5, 91.1, 87.1, 71.40, 71.37, 71.14, 71.07, 29.9, 22.9, 22.8, 10.8; MALDI-TOF MS 
(+eV) m/z calcd for C68H87B30NO8 1371.0, found 1371.0. 
Compound 32. To a round bottom flask with stir bar was added trimer 31 (0.074 g, 
0.054 mmol), Zn powder (0.353 g, 5.39 mmol), 1 drop AcOH, and THF (3.0 mL). The 
mixture was allowed to stir for 1 h and the reaction quenched by elution through a Celite 
pad with CH2Cl2. The resulting residue was then purified using flash chromatography with 
25% CH2Cl2 in hexanes as eluent to give product 32 (0.072 g, 100%) a light yellow solid. 
FTIR (neat) 3568, 3386, 2964, 2934, 2876, 2614, 2364, 2229, 1619, 1605, 1578, 1501, 
1422, 1386, 1276, 1217, 1062, 1015 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.57 (s, 3H), 7.11 (d, 
J = 8.7 Hz, 2H), 6.89 (s, 3H), 6.75 (s, 3H), 6.53 (d,  J = 8.7 Hz, 2H), 3.92 (t, J = 6.5 Hz, 6H), 3.86 
(t, J = 6.2 Hz, 6H), 3.30−1.60 (br m, 46H), 1.06 (t, J = 7.4 Hz, 18H); 13C NMR (100 MHz, 
CDCl3) δ 154.49, 154.48, 153.7, 134.2, 133.5, 124.3, 117.2, 117.11, 117.09, 115.7, 114.7, 
114.5, 112.5, 93.6, 87.1, 76.8, 76.2, 71.4, 71.1, 29.9, 22.9, 22.8, 10.76, 10.75; MALDI-TOF MS 
(+eV) m/z calcd for C68H90B30NO6 1341.0, found 1342.1 [M + H]. 
Trimer 4.  Into a Schlenk tube under nitrogen, trimer 32 (15 mg, 0.011 mmol) was 
dissolved in CH2Cl2 (1 mL) and TEA (0.1 mL). TRITC (5 mg, 0.011 mmol) in solution in DMF 
(1 mL) was added dropwise, and the mixture was stirred overnight in the dark at rt. The 
solvents were removed by rotary evaporation. The resulting residue was then purified 
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using flash chromatography with 10% MeOH in CH2Cl2 as eluent to give 4 (9 mg, 45%) as a 
purple solid.  FTIR (neat) 3350, 2961, 2924, 2853, 2615, 2369, 1596, 1500, 1421, 1365, 
1349, 1218, 1188 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.05 (br s, 1H), 7.89 (d, J = 8.8 Hz, 1H), 
7.74 (br s, 1H), 7.58 (m, 1H), 7.52 (s, 3H), 7.20 (m, 4H), 7.05 (d, J = 9.5 Hz, 1H), 6.85 (s, 3H), 
6.72 (dd, J1 = 8.3 Hz, J2 = 2.0 Hz, 2H), 6.71 (s, 3H), 6.67 (d, J = 2.0 Hz, 2H), 3.88 (t, J = 6.5 Hz, 
6H), 3.82 (t, J = 6.5 Hz, 6H), 3.21 (s, 12H), 3.00−1.47 (br m, 33H), 1.77 (m, 12H), 1.02 (m, 
18H). The material was not soluble enough for 13C analysis. MALDI-TOF MS (+eV) m/z 
calcd for C93H110B30N4O6S 1784.1, found 1785.1 [M + H]. 
Compound 34. A Schlenk tube equipped with a magnetic stir bar was charged with 
3320 (80 mg, 80 µmol) and dry THF (3 mL). The solution was cooled to -30 °C and BuLi (32 
µL, 80 µmol, 2.5 M in hexanes) was added. The solution was allowed to stir at −30°C for 15 
min before CuBr (17 mg, 118 µmol) was added and the mixture was allowed to stir at 
−30°C for 15 min. 30 (18 mg, 80 µmol) was added and the resulting mixture was allowed to 
stir at rt for 16 h. A few drops of water were added, and the mixture was filtered through a 
silica gel pad using CH2Cl2 as the eluent. The resulting greenish solid was purified by 
column chromatography (silica gel, using 50% CH2Cl2 in hexanes) to provide a mixture of 
34 and 34’ as a white powder (15 mg, 16%). FTIR (neat) 3063, 3010, 2960, 2927, 2854, 
2609, 2362, 2344, 2209, 1593, 1528, 1501, 1450, 1407, 1378, 1348, 1278, 1257, 1219, 
1133, 1059, 1039, 1012, 853, 830 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 9.0 Hz, 2H), 
7.49−7.45 (m, 4H), 7.26−7.23 (m, 2H), 7.17−7.15 (m, 2H), 7.07−7.05 (m, 2H), 4.00 (m, 6H), 
3.20−1.60 (br m, 44H); 13C NMR (100 MHz, CDCl3) δ 154.27, 154.23, 147.82, 135.53, 133.03, 
132.35, 132.28, 131.20, 128.11, 128.06, 126.81, 126.68, 124.26, 124.01, 123.70, 122.39, 
122.17, 121.85, 115.82, 113.62, 113.56, 113.40, 11.37, 92.23, 91.18, 92.04, 91.34, 91.17, 
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91.02, 90.89, 90.85, 90.78, 90.08, 88.18, 88.05, 87.60, 79.61, 79.51, 78.50, 78.42, 78.10, 
78.04, 69.69, 69.33, 60.53, 56.66; MALDI-TOF MS (+eV) m/z calcd for C48H61B40NO4 1148.4, 
found 1148.7. 
Compound 35. A Schlenk tube equipped with a magnetic stir bar was charged with 
34 (14 mg, 12 µmol), Zn powder (79 mg, 1.21 mmol), 1 drop AcOH and THF (3.0 mL). The 
mixture was allowed to stir at 30 °C for 15 min. The resulting greenish solid was purified 
by column chromatography (silica gel, hexanes / CH2Cl2 1:1) to provide a mixture of 35 and 
35’ as a white powder (8 mg, 59%). FTIR (neat) 3484, 3387, 3060, 2919, 2851, 2609, 2356, 
2326, 2220, 1719, 1602, 1504, 1460, 1407, 1384, 1284, 1224, 1180, 1145, 1062, 1045, 
1012, 892, 868, 830 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.48−7.49 (m, 2H), 7.23 (d, J = 8.1 
Hz, 2H), 7.14 (dd, J1 = 8.1 Hz, J2 = 1.6 Hz, 2H), 7.11-7.06 (m, 4H), 6.54−6.51 (m, 2H), 4.00 (m, 
6H), 3.81 (br s, 2H), 3.20−1.60 (br m, 44H); 13C NMR (100 MHz, CDCl3) δ 154.23, 147.49, 
135.54, 133.51, 132.33, 131.16, 126.73, 124.04, 123.97, 122.14, 115.81, 114.65, 113.51, 
113.47, 113.40, 110.49, 110.40, 92.15, 92.13, 91.19, 90.96, 90.93, 88.01, 69.69, 69.34, 60.52, 
56.65; MALDI-TOF MS (+eV) m/z calcd for C48H63B40NO2 1118.5, found 1118.9. 
Compound 5. In a Schlenk tube under nitrogen, the aniline nanocar 35 (8 mg, 7 
µmol) was dissolved in CH2Cl2 (1.0 mL) and Et3N (0.1 mL).  TRITC (3 mg, 7 µmol) in DMF 
(1.0 mL) was added dropwise and the mixture was stirred overnight at rt in the dark. The 
solvents were then removed by rotary evaporation under reduced pressure. The resulting 
solid was purified by column chromatography (silica gel, 10% MeOH in CH2Cl2) to yield a 
mixture of 5 and 5’ as a purple solid (3.1 mg, 29%). FTIR (neat) 3337, 3060, 2922, 2854, 
2612, 2362, 2338, 1711, 1593, 1578, 1504, 1460, 1410, 1381, 1260, 1219, 1180, 1104, 
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1062, 1045, 1009, 847 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.95 (br s, 1H), 7.82 (d, J = 8.8 Hz, 
1H), 7.74 (d, J = 8.8 Hz, 1H), 7.58 (d, J = 8.9 Hz, 1H), 7.49−7.48 (m, 3H), 7.15−7.05 (m, 5H), 
6.98 (d, J = 8.4 Hz, 2H), 6.82 (m, 2H), 6.72 (d, J = 8.6 Hz, 1H), 6.46−6.40 (m, 4H), 4.01 (br s, 
6H), 3.00 (br s, 12H), 3.00−1.47 (br m, 43H). The material was not soluble enough for 13C 
analysis. MALDI-TOF MS (+eV) m/z calcd for C73H84B40N4O5S 1561.9, found 1562.0. 
Supporting Information. 1H and 13C NMR spectra of new compounds. 
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1.6. Experimental Contributions Section 
My contributions to the experimental work described in this chapter are the 
following: synthesis and characterization of nanocar 3, as well as measurement of the 
optical properties of the five fluorescently labeled nanocars and their aniline precursors. 
Jason Guerrero conceived the project and synthesized nanocars 1 and 2. Guillaume Vives 
synthesized nanocars 4 and 5. Saumyakanti Khatua developed the correction file used for 
the fluorescence spectra. Yu-Pu-Wang and J. L. Kiappes provided assistance with the 
syntheses of several nanocar precursors. Benaiah E. Tour and Pin-Lei E. Chu synthesized 
axles 6 and 9, respectively.          
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Chapter 2 
Synthesis and Fluorescence Imaging of 
BODIPY-Based Nanocars 
Note: This chapter was copied in large part from two papers that I coauthored.1,2 Reprinted 
with permission from references 1 and 2. Copyright 2010 American Chemical Society.
2.1. Introduction 
The control of motion at the molecular level stands as a challenge for scientists. 
Nature gives the supreme example of such control when the synchronization of motion of 
individual molecules leads to intricate biological functions.3 Unfortunately, the use of 
natural molecular machines for ex vivo applications is intrinsically limited due to 
unfavorable environmental perturbations.4 Much effort has been devoted toward the 
design, synthesis and operation of synthetic molecular machines. As a consequence, a large 
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variety of nanostructures have been made to operate either in solution, in the solid state or 
mounted on surfaces.5  
   Our group has focused on the study of restricted rolling motion to control the 
translation of individual molecules along atomically flat surfaces. Incorporation of either 
C60-fullerene,6 p-carborane7 or a ruthenium complex8 as molecular wheels in flexible 
oligo(phenylene ethynylene) (OPE) chassis has afforded a collection of molecular vehicles 
termed nanocars.9 
Most nanocars have been designed to be observed and tracked using scanning 
tunneling microscopy (STM) since it offers unparalleled atomic resolution.10 Exploration of 
other single-molecule imaging tools, however, is essential in order to observe movement of 
nanomachines on non-conductive surfaces. Single-molecule fluorescence microscopy 
(SMFM) is a good alternative. Even though its resolution is limited by diffraction, 
nanometer localization of individual fluorophores has become possible.11  
As described in chapter 1, a family of five fluorescently-tagged nanocars was 
synthesized, intended for imaging through SMFM.12 The nanocars were functionalized with 
a tetramethylrhodamine fluorescent tag to allow excitation with a Nd:Vn laser (532 nm) 
with good fluorescence quantum yields. The motion of one of the nanocars was monitored 
on a glass surface at ambient conditions.13 The nanocars moved at an average speed of 4 
nm/s at room temperature. However, only 25% of the nanocars studied showed motion, 
suggesting that the fluorophore might interfere with the nanocar motion by blocking some 
of the molecules. In addition, the synthesis of the tagged-nanocars presented some 
drawbacks, such as lengthy routes and low-yielding attachment of the fluorescent label. 
Consequently, a new set of intrinsically fluorescent nanocars was designed to obviate the 
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need for a pendant fluorescent tag. We envisioned that removal of the large pendant 
fluorophore might lead to an increase in the fraction of moving molecules. 
 
Figure 2.1. (Modified from reference 1). Structure of BODIPY-based nanocars 1-3 and 
analogue 4. Every vertex of the carborane wheel is BH except the darkened sites, where the 
outer (para) is CH and the inner (ipso) is alkynyl-substituted C. 
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A modular and convergent route was used to synthesize fluorescent nanocars 1-3 
and the analogue 4 that each incorporate a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
(BODIPY) core14 in their axles (Figure 2.1). The BODIPY moiety is a versatile fluorophore; 
BODIPY-based chromophores tend to exhibit good thermal and photochemical stability, 
high fluorescence quantum yields, intense absorption profiles, tunability of absorption 
range and good solubility in most organic solvents.15 Furthermore, the geometry of the core 
yields nanocars where the chassis is perpendicular to the axles, leading to only one 
conformation on the surface, in contrast to the previous ‘Z-shaped’ chassis obtained from 
OPE-axle-based nanocars.9 
The mobility of nanocar 2 was studied on three surfaces: plasma cleaned, reactive 
ion etched, and amine-functionalized glass. Using single-molecule fluorescence 
spectrocsopy, the percentage of moving nanocars and their diffusion constants were 
determined for each substrate. 
2.2. Results and Discussion 
2.2.1. Synthesis of Nanocars 
Nanocars 1 and 2 were designed to move in a straight line on sufaces while nanocar 
3 is expected to exhibit circular surface motion that could be detected by measuring the 
polarization anisotropy distribution.16 In order to confirm the importance of the p-
carborane wheels in translational motion, nanocar analogue 4, bearing tert-butyl groups 
instead of the p-carborane clusters, was also designed and synthesized. 
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Our synthetic strategy was based upon the realization that nanocars 1-3 (Figure 
2.1) could be assembled by coupling two units of a BODIPY-containing axle with the 
appropriate inner portion or via a homocoupling. By incorporating the fluorophore in the 
axle, a modular synthesis of nanocars with various chassis is accessible. The tert-butyl-
substituted analogue 4 could be analogously assembled using a different axle. Both axles 
were synthesized from known BODIPY 517 using the 2,6-acetylenic functionalization first 
explored by Ziessel.18 
 
Scheme 2.1.1 Synthesis of axle 10. 
 
The synthesis of axle 10 (Scheme 2.1) started with a Sonogashira coupling reaction 
between BODIPY 5 and trimethylsilylacetylene (TMSA) that afforded 6. Double iodination 
of the BODIPY core in 6 using N-iodosuccinimide (NIS) gave 7. Diiodide 7 was then 
subjected to a double Sonogashira coupling with 1-ethynyl-p-carborane 819 to give 9, 
which upon TMS deprotection afforded axle 10. Fluoride sources were avoided for 
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deprotection since they are known to give lower yields due to partial destruction of the 
BODIPY core.20 It is noteworthy that, in our experience, reaction times longer than 1.5 h 
with the K2CO3/MeOH system also reduce the yield and lead to formation of unknown 
byproducts. In summary, axle 10 was prepared in four steps from BODIPY 5 with an 
overall yield of 58%.  
Nanocar 1 was assembled by palladium-catalyzed homocoupling of axle 10 in the 
presence of air (Scheme 2.2). The reaction was complete in 10 min and the product was 
obtained in high yield. In contrast, Eglinton-Glaser conditions21 led only to decomposition 
of 10, probably due to substitution of the boron by the Cu(II) required in the process.22  
Axle 10 was also used in the final assembly of nanocars 2 and 3 (Scheme 2.2). 
Synthesis of nanocar 2 was accomplished through Sonogashira coupling between 1,4-
diiodo-2,5-dimethoxybenzene (11)23 and three equivalents of 10 to give 2 using typical 
coupling conditions. A methoxy substituted benzene was used as the inner portion to allow 
easier purification away from the byproduct nanocar 1. Similarly, to obtain nanocar 3, 9-
butyl-3,6-diiodo-9H-carbazole (12)24 was coupled with three equivalents of axle 10 to give 
the desired nanocar 3. 
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Scheme 2.2. (Modified from reference 1). Synthesis of nanocars 1−3. 
 
In order to address the importance of the carborane wheels in translational motion, 
their replacement by a non-wheel-like group was desired. Introduction of small alkyl 
chains was considered since they are not expected to significantly modify the fluorescence 
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of the BODIPY core. Lacking the wheel-like structure of p-carborane, an alkyl-substituted 
analogue would also enable us to evaluate the influence of the p-carborane on the 
absorption and emission properties of the BODIPY core. To prepare analogue 4, bisiodide 7 
was coupled with 3,3-dimethyl-1-butyne to give the TMS-protected axle 13. After nearly 
quantitative deprotection, the free alkyne 14 was subjected to the final coupling with 11 to 
give the nanocar analogue 4 in excellent yield (Scheme 2.3). 
 
Scheme 2.3.1 Synthesis of nanocar analogue 4. 
 
The efficiency of the coupling reactions to obtain 1−3 suggests that the BODIPY-
containing axle 10 is a versatile building block to prepare even more complex nanocars by 
varying the inner portion. 
2.2.2. Synthesis of a Trimer 
To evaluate the importance of a car-like arrangement of the carborane wheels to 
observe translational motion, we also synthesized a BODIPY trimer in which only two of its 
three carborane wheels are aligned.  
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Trimer 16 (Scheme 2.4) was synthesized in two steps. First, a double iodination of 
BODIPY 5 using NIS provided 15. Next, triiodide 15 reacted with1-ethynyl-p-carborane 8 
under conventional Sonogashira coupling conditions to afford trimer 16.   
Scheme 2.4.2 Synthesis of trimer 16.  
 
2.2.3. Optical Properties 
The optical properties of the nanocars, the trimer, and some precursors were 
investigated by UV−vis and fluorescence spectroscopy (Table 2.1). The photophysical 
behavior of some of the compounds reported here was particularly interesting given that 
there was no previous report of carborane−BODIPY diads.25 The absorption spectrum of all 
compounds exhibit a strong S0→S1 (π–π*) transition located between 504 and 564 nm with 
variable extinction coefficients depending on the substitution pattern. The molecules with 
two BODIPY units have the largest extinction coefficients due to the extension in the 
conjugated system. The tert-butyl substituted compounds are slightly bathochromically 
shifted compared to their carboranyl-susbstituted analogues, probably due to the stronger 
electron-donating character of the tert-butyl groups.   
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compd abs (nm) ε (M-1cm-1) em (nm) ΦFa 
1 554 123 000 571 0.69 
2 552 181 000 569 0.70 
3 552 191 000 567 0.79 
4 564 144 000 586 0.59 
6 504 70 000 514 0.46 
7 538 90 000 552 0.04 
9 552 109 000 567 0.82 
10 552 116 000 567 0.85 
13 564 59 000 586 0.58 
14 564 69 000 586 0.62 
16 552 83 000 568 0.85 
Table 2.1.1 Optical properties of all compounds. aDetermined in chloroform solution, ca. 1 
 10-7 M. Using rhodamine 6G as reference, ΦF = 0.95 in EtOH, exc 488 nm. Excitation was 
done at the corresponding max − 30 nm wavelength.  
 
Diiodo BODIPY 7 exhibits very low fluorescence quantum yield, in part due to 
efficient intersystem crossing caused by the heavy iodine atom, leading to a low lying 
triplet state.26 The fluorescence was restored, however, upon introduction of the alkynyl 
carborane wheels or the alkynyl tert-butyl groups and was retained after the final 
assembly. The presence of the carboranes enhanced the quantum yields (compare 10 with 
14 and 2 with 4). The fluorescence quantum yields of nanocars 1−3 are slightly smaller 
than that of the BODIPY axle 10 possibly due to partial through-bond energy transfer 
between the two BODIPY units. 
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Figure 2.2.  (Modified from reference 1). Absorption and emission spectra of 1−4 . (A) 
UV−vis absorption spectra of 1−4 in CHCl3. (B) Fluorescence spectra of 1−4 in CHCl3. 
Excitation done at λmax −30 nm. 
  
Since our current SMFM setup requires excitation of the molecules with a 514 nm 
laser, it was a prerequisite for the nanocars to exhibit reasonable absorption at this 
wavelength. As depicted in Figure 2.2, both nanocars, analogue, and trimer (1-4 and 16) 
absorb in this region. Furthermore, the high fluorescence quantum yields of the three 
nanocars and the trimer make them particularly well-suited for imaging by SMFS at the 
excitation wavelengths. 
2.2.4. Fluorescence Microscopy 
The mobility of nanocar 2 was studied on three substrates: plasma cleaned glass, 
reactive ion etched glass, and amine-functionalized glass. Nanocars were deposited on 
different substrates by spin coating them from a 10-12 M solution in chloroform. The 
mobility of individual nanocars 2 was determined from time-lapsed confocal fluorescence 
images. Figure 2.3A shows the first of a series of images taken for nanocars dispersed on 
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plasma cleaned glass coverslips. The bright spots in the fluorescence image correspond to 
individual nanocars. As illustrated in Figure 2.3B, two-dimensional trajectories of the 
nanocar motion were computed from the entire series of images taken over the same area 
using a single-molecule tracking algorithm that can account for fluorescence blinking and 
bleaching.27 The single-molecule trajectories were each analyzed to give a two-dimensional 
diffusion constant (Figure 2.3C), enabling a quantitative comparison between different 
nanocars and surfaces. 
 
Figure 2.3. (Modified from reference 2). Fluorescence images of nanocar 2 on glass. (A) 
First of a time series of fluorescence images for single nanocars on a plasma-cleaned glass 
substrate. Individual nanocars indicated by the red circles were identified based on a 
threshold intensity. (B) XY trajectories of the nanocars identified in panel A. Trajectories 
colored red and green indicate “moving” and “stationary” nanocars, respectively. (C) 
Squared displacements SD versus time t calculated from the single nanocar trajectory 
surrounded by the green dotted square in panel B. A linear fit according to SD = 4Dt gives a 
diffusion constant of D = 4.610-16 m2/s.  
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On plasma cleaned glass, 45% (126 out of 279) of nanocars 2 showed motion. This 
percentage was nearly double than the fraction of moving TRITC-tagged nanocars 17 
(Figure 2.4), which were studied under identical conditions.13 Removal of the TRITC tag 
might have contributed to the increase in moving molecules. However, it is difficult to 
quantify that contribution due to the profound structural differences between nanocars 17 
and 2; the zwitterionic nature of TRITC can promote electrostatic interactions of the 
nanocar with the glass surface; also, the ‘Z-shaped’ chassis of nanocar 17 leads to more 
possible conformations on a surface than the linear chassis of nanocar 2.   
 
 
 
 
 
 
 
Figure 2.4.2 Structures of the TRITC-tagged (17) and BODIPY-based (2) nanocars. Every 
vertex on the p-carboranes is BH, except the black dots, where the outer (para) is CH and 
the inner (ipso) is alkynyl-substituted C.  
 
Although the fraction of moving molecules increased, the magnitude of D was 
similar for nanocars 17 and 2 (Figure 2.5A). These results suggest that, although 
structurally different, a common feature between nanocars 17 and 2 must account for the 
similarity. Since both 17 and 2 contain four p-carborane wheels, it is possible that the 
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magnitude of D in moving nanocars is mainly governed by the interactions between the 
substrate and the nanocar wheels.  
 
 
Figure 2.5. (Modified from reference 2). Distribution of single-molecule diffusion constants 
of nanocar 2 on three different substrates. (A) Distribution of single-molecule diffusion 
constants D for the moving BODIPY nanocars 2 on glass (bars). For comparison, the 
histogram of diffusion constants for  TRITC-tagged nanocar 17 with carborane wheels 
moving on a glass surface is also included (line). The mean diffusion constants are nearly 
identical with D=2.410-16 m2/s and D=2.210-16m2/s, for nanocars 2 and 17, respectively. 
(B,C) Histograms of diffusion constants for nanocars on reactive ion-etched and amine-
terminated glass. Nm and Ns are the number of moving and stationary nanocars, 
respectively. 
 
To test if the movement for the majority of the nanocars was consistent with a 
rolling-type motion, the mobility of BODIPY-based trimer 16 (Figure 2.6) was studied. 
Under the same experimental conditions, it was found that only ∼10% of the trimers 
moved on glass. Because of the perpendicular orientation of the third wheel, a rolling-type 
motion was hindered, as was predicted. The opposite trend is expected for motion by 
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hopping or slipping due to the decrease in the number of wheels and hence surface 
interaction.  
 
Figure 2.6. Structure of trimer 16. 
To investigate the impact of surface roughness and nanocar-substrate interactions 
on the mobility, nanocar 2 was then studied on reactive ion etching (RIE) treated glass and 
VectabondTM treated glass (Figure 2.5B and 2.5C, respectively). Based on atomic force 
microscopy (AFM) analysis, the RIE process increased the average surface roughness (Ra) 
from 0.4 ± 0.1 nm in intact glass to 2.6 ± 0. 2 nm in etched glass. VectabondTM was utilized 
to functionalize the glass surface with amine groups.28 A significant decrease in the fraction 
of moving nanocars and their diffusion constants took place in both surfaces. Only 18% of 
the molecules moved on RIE-etched glass, while on VectabondTM-functionalized glass the 
percentage dropped to 13%. 
   The results from RIE-etched glass showed that an increase in surface roughness 
decreases the fraction of moving molecules. Some molecules might become lodged in the 
surface irregularities. Therefore, the lack of motion by almost half the nanocars 2 on 
plasma cleaned glass might be due, at least partially, to surface irregularities. 
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In the VectabondTM treated glass, AFM showed holes as big as 50 nm in diameter 
and 5 nm in height, most likely due to uneven functionalization of the glass. However, these 
holes constitute less than 3% of the total surface area. The rest of the surface has an Ra 
similar to untreated glass. Consequently, a different factor should be responsible of the 
remarkable drop in moving molecules and in their diffusion constant. On glass, carborane 
can form hydrogen bonds of the type B−H∙∙∙O (~ 1.1 kcal/mol for hydroxyl-terminated 
glass)29 with the surface. On the other hand, amines can form unusual dihydrogen bonds of 
the type B−H∙∙∙H−N (2.1 – 5 kcal/mol)30,31 with boranes and carboranes. Therefore, the 
surface-carborane interactions are stronger in the VectabondTM treated glass than in intact 
glass, which might account for the lower fraction of moving molecules and smaller diffusion 
constant. 
2.3. Conclusions 
In summary, the synthesis of three BODIPY-containing highly fluorescent nanocars, 
one analogue, and a trimer was achieved using a modular approach that involves a 
versatile BODIPY containing axle. The nanocars were prepared in five steps with overall 
yields of 49%, 45%, and 46% for 1, 2, and 3, respectively. Electronic spectroscopic studies 
revealed that the nanocars exhibit absorption centered around 550 nm and have high 
fluorescence quantum yields. 
Through the study of the motion of BODIPY-based nanocar 2 in glass, we have 
shown that a significant improvement in the number of moving molecules can be achieved 
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with an intrinsically fluorescent nanocar. Furthermore, we found that both the surface 
roughness and the interaction strength between the nanocar wheels and the substrate are 
important factors in determining the percentage of moving nanocars and their speeds. 
When changing the surface from hydroxyl to amine termination, the speed decreased 2-
fold from 4.2 to 2.1 nm/s. 
2.4. Experimental Section 
General Methods. 1H NMR and 13C NMR spectra were recorded at 400 or 500 and 
100 or 125 MHz, respectively. Chemical shifts () are reported in ppm from 
tetramethylsilane (TMS). Mass spectrometry was performed at Rice University or the 
University of South Carolina Mass Spectrometry Laboratory. All MALDI-TOF experiments 
were performed using alpha cyano-4-hydroxy-cinnamic acid as the matrix. FTIR spectra 
were recorded using a Nicolet FTIR Infrared Microscope with ATR objective with 2 cm-1 
slit. Melting points were not recorded since the compounds did not melt below 200 °C. 
Reagent grade tetrahydrofuran (THF) was distilled from sodium benzophenoneketyl. 
Triethylamine (Et3N), dichloromethane (CH2Cl2) and 1,2-dichloroethane were distilled 
from CaH2 under N2 atmosphere. Hexanes were distilled. Optima grade chloroform (CHCl3) 
was used. THF and Et3N were degassed with a stream of argon for 30 min before being 
used in the Sonogashira coupling reactions. 2,4-dimethylpyrrole was distilled from CaH2 
under nitrogen atmosphere. Trimethylsilylacetylene (TMSA) was donated by FAR Research 
Inc. or Petra Research. All other chemicals were purchased from commercial suppliers and 
used without further purification. Flash column chromatography was performed using 
230-400 mesh silica gel from EM Science. Thin layer chromatography (TLC) was performed 
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using aluminum plates pre-coated with silica gel 60 F254 0.20 mm layer thickness 
purchased from Sigma Aldrich. The synthesis of 1-ethynyl-p-carborane 8,17 1,4-diiodo-2,5-
dimethoxybenzene 1123 and 9-butyl-3,6-diiodo-9H-carbazole 1224 was performed according 
to the literature procedures.  
Spectroscopic Measurements. Absorption spectra were recorded on a Shimadzu 
UV-3101PC spectrophotometer. UV−vis spectra have 2 nm slit. The fluorescence emission 
spectra were obtained in a Perkin Elmer LS50B instrument, using CHCl3 solutions exposed 
to air with absorbance between 0.01 − 0.06. Two emission spectra were recorded for each 
compound and the two quantum yields obtained were then averaged. All fluorescence 
spectra were corrected. Excitation was done at the corresponding max - 30 nm wavelength. 
Rhodamine 6G was used as the reference (ref = 0.95 in EtOH, exc = 488 nm).32 The 
fluorescence quantum yields were calculated from eq. 1. F denotes the integral of the 
corrected fluorescence spectrum, A is the absorbance at the excitation wavelength and n is 
the refractive index of the medium. 
                                        Φ    Φ   
                     
 
                       
                                         (2.1) 
General Procedure for the Coupling of a Terminal Alkyne with an Aryl Iodide 
Using a Palladium-Catalyzed Cross-Coupling (Sonogashira) Protocol. To an oven-dried 
round bottom flask or Schlenk tube equipped with a magnetic stir bar were added the aryl 
halide, the terminal alkyne, PdCl2(PPh3)2 (ca. 5 mol% per aryl halide) and CuI (ca. 10 mol% 
per aryl halide). A solvent system of THF:Et3N 3:1 was well-degassed under argon for 30 
min prior to addition to the reaction mixture. Upon completion, the reaction was quenched 
with a saturated solution of NH4Cl. The organic layer was then diluted with CH2Cl2 (2) and 
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washed with water or saturated NH4Cl (1). The combined aqueous layers were extracted 
with CH2Cl2 (2). The combined organic layers were dried over MgSO4, filtered, and the 
solvent was removed from the filtrate in vacuo to afford the crude product, which was 
purified by column chromatography (silica gel). Eluents and other slight modifications are 
described below for each compound. 
BODIPY 5.17 (Modified procedure33). p-iodobenzoyl chloride (2238 mg, 8.4 mmol) 
was added to an oven-dried 250 ml round bottom flask and then was dissolved in freshly 
distilled 1,2-dichloroethane (150 mL). Freshly distilled 2,4-dimethylpyrrole (1.7 mL, 16.8 
mmol) was added via syringe. After 13 hr at reflux, the mixture was cooled to room 
temperature and then triethylamine (6.0 mL, 42.6 mmol) was added. Borontrifluoride 
etherate (9.0 mL, 72.24 mmol) was added after stirring the mixture 10 min. The mixture 
was heat at reflux for 2 h. The solvent was removed in vacuo and the residue was purified 
on a silica gel column using 3-5% EtOAc in hexanes as eluent to give 5 as an orange solid 
with metallic luster (901 mg, 2.00 mmol, 24%). 1H NMR (400 MHz, CDCl3, ppm)  7.85 (d, 
2H J = 8.0 Hz), 7.05 (d, 2H J = 8.0 Hz), 5.99 (s, 2H), 2.55 (s, 6H), 1.42 (s, 6H). 
TMS-protected BODIPY 6. See the general procedure for the Pd/Cu coupling 
reaction. The materials used were 5 (437 mg, 0.97 mmol), Pd[PPh3]2Cl2 (34 mg, 0.048 
mmol), CuI (19 mg, 0.097 mmol), THF (8 mL) and Et3N (3 mL). TMSA (0.17 mL, 1.17 mmol) 
was added via syringe and the mixture was stirred at room temperature for 16 h. The 
residue was purified by flash column chromatography (silica gel, 20% CH2Cl2 in hexanes) 
to provide 6 (405 mg, 0.964 mmol, 99%) as an orange solid. FTIR (neat) 3089, 3045, 2960, 
2925, 2851, 2320, 2161, 1537, 1513, 1463, 1407, 1307, 1245, 1183, 1156 cm−1; 1H NMR 
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(400 MHz, CDCl3, ppm)  7.60 (d, 2H J = 8.0 Hz), 7.24 (d, 2H J = 8.0 Hz), 5.98 (s, 2H), 2.55 (s, 
6H), 1.40 (s, 6H), 0.28 (s, 9H); 13C NMR (100 MHz, CDCl3, ppm)  156.0, 143.2, 140.9, 135.4, 
132.9, 131.3, 128.3, 124.1, 121.5, 104.4, 96.0, 14.82, 14.80, 0.1; EI-HRMS m/z calcd for 
C24H27BF2N2Si 420.1995, found 420.2005. 
Diiodo BODIPY 7. A 100 mL round-bottom flask equipped with a magnetic stir bar 
was charged with 6 (850 mg, 2.02 mmol), 30 mL of CH2Cl2 and 10 mL of DMF. N-
iodosuccinimide (1136 mg, 5.05 mmol) was added and the orange solution was stirred at 
room temperature for 21 h. A red solution was obtained. The CH2Cl2 was removed in 
vacuum and the residue was treated with 100 mL of water. The mixture was then extracted 
with Et2O (100 mL × 3). The combined organic fractions were mixed with 50 mL of CH2Cl2 
and then dried with MgSO4. The solvent was removed in vacuum and the residue was 
purified by flash column chromatography (silica gel, 40% CH2Cl2 in hexanes) to provide 7 
(1.14 g, 1.70 mmol, 84%) as a red solid. FTIR (neat) 2951, 2916, 2848, 2359, 2318, 2153, 
1525, 1443, 1404, 1345, 1301, 1245, 1171 cm−1;  1H NMR (400 MHz, CDCl3, ppm)  7.63 (d, 
2H J = 8.0 Hz), 7.21 (d, 2H J = 8.0 Hz), 2.64 (s, 6H), 1.41 (s, 6H), 0.29 (s, 9H); 13C NMR (125 
MHz, CDCl3, ppm)  157.3, 145.4, 140.6, 135.0, 133.2, 131.3, 128.1, 124.8, 104.1, 96.7, 86.1, 
17.4, 16.3, 0.12; EI-HRMS m/z calcd for C24H25BF2I2N2Si 671.9936, found 671.9938.     
TMS-protected axle 9. See the general procedure for the Pd/Cu coupling reaction. 
The materials used were 7 (400 mg, 0.59 mmol), 8 (300 mg, 1.78 mmol), Pd[PPh3]2Cl2 (42 
mg, 0.06 mmol) and CuI (23 mg, 0.12 mmol), THF (7.5 mL) and Et3N (2.5 mL). The mixture 
was stirred at 50 C for 7 h. The crude was purified by column chromatography (silica gel, 
20% CH2Cl2 in hexanes as eluent) to provide 9 (396 mg, 0.53 mmol, 88%) as a red solid. 
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FTIR (neat) 3060, 2957, 2922, 2895, 2854, 2603, 2238, 2158, 1528, 1481, 1392, 1319, 
1260, 1186 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  7.59 (d, 2H J = 8.0 Hz), 7.12 (d, 2H J = 
8.0 Hz), 3.20-1.50 (br m, 28H), 1.32 (s, 6H), 0.29 (s, 9H); 13C NMR (100 MHz, CDCl3, ppm)  
159.1, 145.4, 142.3, 134.2, 133.1, 131.0, 127.9, 124.8, 114.7, 104.0, 96.7, 93.3, 72.1, 70.0, 
59.9, 13.7, 0.08; EI-HRMS m/z calcd for C32H47B21F2N2Si 752.5588, found 752.5597.     
Axle 10. A 100 mL round-bottom flask equipped with a magnetic stir bar was 
charged with 9 (360 mg, 0.48 mmol), 15 mL of MeOH and 15 mL of THF. K2CO3 was added 
(99 mg, 0.72 mmol) and the mixture was stirred at room temperature for 1 h. The reaction 
was quenched with 30 mL of 15% NH4Cl and then extracted with CH2Cl2 (50 mL × 2). The 
combined organic fractions were dried with MgSO4 and evaporated in vacuum. The residue 
was purified by column chromatography (silica gel, 20% CH2Cl2 in hexanes) to provide 10 
(256 mg, 0.38 mmol, 79%) as a red solid. FTIR (neat) 3276, 3061, 2952, 2925, 2854, 2226, 
2158, 1521, 1481, 1396, 1319, 1259, 1183 cm−1;  1H NMR (400 MHz, CDCl3, ppm)  7.61 (d, 
2H J = 8.0 Hz), 7.15 (d, 2H J = 8.0 Hz), 3.21 (s, 1H), 3.18-1.60 (br m, 28H), 1.33 (s, 6H); 13C 
NMR (125 MHz, CDCl3, ppm)  159.2, 145.4, 142.1, 134.7, 133.3, 131.0, 128.1, 123.9, 114.8, 
93.3, 82.8, 79.3, 72.1, 70.0, 60.0, 13.7; EI-HRMS m/z calcd for C29H39B21F2N2 680.5195, 
found 680.5199. 
Nanocar 1. Axle 10 (8 mg, 0.012 mmol), Pd[PPh3]2Cl2 (2 mg, 2.8 µmol), CuI (1.1 mg, 
6 µmol), THF (3 mL) and Et3N (1 mL) were added to a Schlenk tube open to air. The 
mixture was stirred for 10 min at room temperature. Since axle 10 was consumed 
according to TLC, the solvent was removed. The residue was purified by column 
chromatography (silica gel, 30% CHCl3 in hexanes) to provide nanocar 1 (6.8 mg, 0.005 
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mmol, 85%) as a red solid. FTIR (neat) 3060, 2922, 2654, 2612, 2359, 2323, 2238, 1528, 
1479, 1389, 1319, 1260, 1183 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  7.67 (d, 4H J = 8.0 
Hz), 7.20 (d, 4H J = 8.0 Hz), 3.30-1.58 (br m, 56H), 1.35 (s, 12H); 13C NMR (100 MHz, CDCl3, 
ppm)  159.4, 145.3, 141.8, 135.3, 133.6, 130.9, 128.3, 123.3, 114.9, 93.4, 81.4, 75.5, 72.0, 
69.9, 60.0, 13.7; MALDI m/z calcd for C58H76B42F4N4 1359.3, found 1359.1.   
Nanocar 2. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were axle 10 (28 mg, 41.0 µmol), 1,4-dimethoxy-2,5-diiodobenzene 11 (5.7 
mg, 14.6 µmol), Pd[PPh3]2Cl2 (1 mg, 1.4 µmol) and CuI (0.5 mg, 2.7 µmol). 3 mL of a 3:1 
THF:Et3N mixture were added inside a dry box. The mixture was stirred at 50 ºC for 6 h. 
The solvent was removed in vacuum and the resultant solid was purified by column 
chromatography in silica gel (25-35% CHCl3 in hexanes). Nanocar 2 was obtained (17.5 mg, 
11.4 µmol, 78%) as a red solid. FTIR (neat) 3063, 2957, 2919, 2851, 2612, 2365, 2323, 
2238, 1722, 1531, 1460, 1395, 1322, 1263, 1186 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  
7.70 (d, 4H J = 8.0 Hz), 7.18 (d, 4H J = 8.0 Hz), 7.09 (s, 2H) 3.95 (s, 6H), 3.30-1.58 (br m, 
56H), 1.36 (s, 6H); 13C NMR (125 MHz, CDCl3, ppm)  159.2, 154.2, 145.4, 142.3, 134.2, 
132.8, 131.0, 128.0, 124.8, 115.8, 114.7, 113.4, 94.4, 93.3, 87.6, 72.1, 70.0, 60.0, 56.7, 13.7; 
MALDI m/z calcd for C66H84B42F4N4O2 1495.4, found 1495.2.   
Nanocar 3. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were 10 (64 mg, 0.09 mmol), 9-butyl-3,6-diiodo-9H-carbazole 12 (15 mg, 
0.03 mmol), Pd[PPh3]2Cl2 (4.5 mg, 0.006 mmol) and CuI (2.5 mg, 0.013 mmol). 2.5 mL of a 
3:1 THF:Et3N mixture were added inside a dry box. The mixture was stirred at room 
temperature for 14 h. The solvent was removed in vacuo and the resultant solid was 
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purified by column chromatography (silica gel using 10-25% CH2Cl2 in hexanes) to provide 
3 (40 mg, 0.025 mmol, 80%) as a red solid. FTIR (neat) 3060, 2957, 2922, 2857, 2606, 
2359, 2321, 2229, 2209, 1528, 1478, 1392, 1319, 1263, 1183 cm−1; 1H NMR (400 MHz, 
CDCl3, ppm)  8.33 (d, 2H J = 4.0 Hz), 7.71 (m, 6H), 7.44 (d, 2H J = 8.0 Hz), 7.19 (d, 4H J = 8.0 
Hz), 4.34 (t, 2H, J = 7.0 Hz), 3.20-1.60 (br m, 60H), 1.40 (s, 12H), 1.00 (t, 3H, J = 7.0 Hz); 13C 
NMR (125 MHz, CDCl3, ppm)  159.1, 145.5, 142.6, 141.0, 133.6, 132.6, 131.1, 130.1, 128.0, 
125.5, 124.6, 122.7, 114.7, 113.6, 109.5, 93.3, 92.8, 87.2, 72.1, 70.0, 68.2, 59.9, 44.0, 31.3, 
25.8, 20.8, 14.1, 13.75, 13.70; MALDI m/z calcd for C74H92B42F4N5 1581.6, found 1581.2.  
TMS-protected axle 13. See the general procedure for the Pd/Cu coupling reaction. 
The materials used were 7 (188 mg, 0.28 mmol), 3,3-dimethyl-1-butyne (0.1 mL, 0.84 
mmol), Pd[PPh3]2Cl2 (19.5 mg, 27.9 µmol), CuI (11 mg, 56.0 µmol), THF (6 mL) and Et3N (2 
mL). The mixture was stirred at room temperature for 12 h. The crude was purified by 
column chromatography (silica gel using 25-30% CH2Cl2 in hexanes) to provide 13 (99 mg, 
0.17 mmol, 61%) as a red solid. FTIR (neat) 2966, 2925, 2863, 2603, 2326, 2288, 2164, 
1531, 1469, 1398, 1360, 1263, 1198 cm−1; 1H NMR (500 MHz, CDCl3, ppm)  7.60 (d, 2H J = 
8.0 Hz), 7.19 (d, 2H J = 8.0 Hz), 2.59 (s, 6H), 1.43 (s, 6H), 1.27 (s, 18H), 0.29 (s, 9H); 13C NMR 
(125 MHz, CDCl3, ppm)  158.3, 143.3, 141.0, 135.2, 133.0, 130.8, 128.3, 124.4, 117.1, 106.2, 
104.3, 96.2, 70.9, 31.4, 28.5, 13.7, 13.6, 0.1; EI-HRMS m/z calcd for C36H43BF2N2Si 580.3263, 
found 580.3257. 
Free Axle 14. A 25 mL round-bottom flask equipped with a magnetic stir bar was 
charged with 13 (85 mg, 0.15 mmol), 5 mL of MeOH and 5 mL of THF. K2CO3 was added (24 
mg, 0.17 mmol) and the mixture was stirred at room temperature for 1 h. The reaction was 
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quenched with 10 mL of 15% NH4Cl and then extracted with CH2Cl2 (20 mL × 2). The 
combined organic fractions were dried with MgSO4 and evaporated in vacuo. The residue 
was purified by column chromatography (silica gel, 40% CH2Cl2 in hexanes) to provide 14 
(74 mg, 0.14 mmol, 99%) as a red solid. FTIR (neat) 3272, 2969, 2925, 2866, 2329, 2288, 
2226, 2117, 1525, 1466, 1395, 1363, 1257, 1201, 1163 cm−1; 1H NMR (500 MHz, CDCl3, 
ppm)  7.62 (d, 2H J = 8.0 Hz), 7.22 (d, 2H J = 8.0 Hz), 3.19 (s, 1H), 2.60 (s, 6H), 1.43 (s, 6H), 
1.27 (s, 18H); 13C NMR (125 MHz, CDCl3, ppm)  158.3, 143.2, 140.8, 135.5, 133.1, 130.8, 
128.4, 123.4, 117.1, 106.3, 83.0, 78.9, 70.9, 31.4, 28.5, 13.7, 13.6; EI-HRMS m/z calcd for 
C33H35BF2N2 508.2862, found 508.2861. 
Nanocar analogue 4. See the general procedure for the Pd/Cu coupling reaction. 
The materials used were 14 (60 mg, 0.12 mmol), 1,4-dimethoxy-2,5-diiodobenzene 11 (18 
mg, 0.046 mmol), Pd[PPh3]2Cl2 (3 mg, 4.0 µmol) and CuI (1.5 mg, 8.0 µmol). 3 mL of a 3:1 
THF:Et3N mixture were added inside a dry box. The mixture was stirred at room 
temperature for 12 h. The solvent was removed in vacuo and the resultant solid was 
purified by column chromatography (silica gel, 50% - 70% CHCl3 in hexanes) to provide 4 
(51 mg, 0.044 mmol, 96%) as a red solid. FTIR (neat) 2966, 2919, 2857, 2326, 2226, 1531, 
1466, 1395, 1366, 1313, 1260, 1195 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  7.71 (d, 4H J = 
8.0 Hz), 7.25 (d, 4H J = 8.0 Hz), 7.09 (s, 2H), 3.95 (s, 6H), 2.61 (s, 12H), 1.45 (s, 12H), 1.28 (s, 
36H); 13C NMR (125 MHz, CDCl3, ppm)  158.4, 154.3, 143.2, 141.1, 135.1, 132.7, 130.9, 
128.4, 124.4 , 117.1, 115.8, 113.5, 106.3, 94.7, 87.3, 70.9, 56.8, 31.5, 28.4, 13.72, 13.68; 
MALDI m/z calcd for C74H76B2F4N4O2 1151.0, found 1150.7. 
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BODIPY 15: A 25 mL round-bottom flask equipped with a magnetic stir bar was 
charged with BODIPY 5 (100 mg, 0.22 mmol), 5 mL of CH2Cl2, and 5 mL of DMF.  N-
iodosuccinimide (130 mg, 0.58 mmol) was added and the orange solution was stirred at 
room temperature for 30 hours. A red solution was obtained. The CH2Cl2 was removed 
under vacuum and the residue was treated with 10 mL of water. The mixture was then 
extracted with Et2O (25 mL × 3). The combined organic fractions were mixed with 20 mL of 
CH2Cl2 and then dried with MgSO4. The solvent was removed under vacuum and the 
residue was purified by flash column chromatography (silica gel, 40% CH2Cl2 in hexanes) 
to provide 15 (123 mg, 0.17 mmol, 79%) as a red solid. FTIR (neat) 2957, 2918, 2850, 
2360, 2341, 1539, 1400, 1190, 1181 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  7.88 (d, 2H, J = 
8.0 Hz), 7.02 (d, 2H, J = 8.0 Hz), 2.64 (s, 6H), 1.43 (s, 6H); 13C NMR (100 MHz, CDCl3, ppm)  
157.4, 145.3, 139.9, 138.9, 134.5, 131.2, 129.9, 95.6, 86.2, 17.5, 16.3; EI-HRMS m/z calcd for 
C19H15BF2I3N2 [M−H]− 701.8428, found 700.8439. 
BODIPY-based trimer 16: A Schlenk tube equipped with a magnetic stir bar was 
filled with 15 (100 mg, 0.14 mmol), 8 (110 mg, 0.64 mmol), Pd[PPh3]2Cl2 (10 mg, 14.2 
µmol), CuI (5.5 mg, 28.4 µmol), THF (9 mL), and Et3N (3 mL). The solvent mixture of 
THF:Et3N = 3:1 was well-degassed under argon for 30 minutes prior to addition of the 
reactants. The solution was then stirred overnight at 50 C. The reaction was quenched 
with a saturated solution of NH4Cl. The organic layer was then diluted with CH2Cl2 (2).  
The aqueous layer was extracted with CH2Cl2 once. The combined organic layers were 
dried over MgSO4. The solvent was removed under vacuum and the residue was purified by 
column chromatography (silica gel, 30-35% CHCl3 in hexanes) to provide 16 (57 mg, 0.069 
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mmol, 49%) as a red solid.  FTIR (neat) 3066, 2922, 2852, 2609, 2360, 2342, 1537, 1476, 
1394, 1319, 1261, 1186, 1057, 1013 cm−1; 1H NMR (500 MHz, CDCl3, ppm)  7.43 (d, 2H, J = 
8.0 Hz), 7.09 (d, 2H, J = 8.0 Hz), 3.3−1.7 (br m, 39H), 1.28 (s, 6H); 13C NMR (125 MHz, CDCl3, 
ppm)  159.2, 145.3, 141.9, 134.8, 133.0, 130.9, 128.0, 123.0, 114.7, 93.3, 87.3, 78.3, 72.0, 
70.0, 69.3, 60.6, 59.9, 13.7 (overlap of two CH3); EI-HRMS m/z calcd for C31H4811B2510B6 
F2N2 [M−H]− 821.6819, found 821.6856. 
Experimental Microscope Setup. Single nanocars were deposited on different 
substrates by spin coating them from a 10-12 mol/L solution in chloroform (Sigma Aldrich) 
at 3000 rpm for 60 s. Glass coverslips (Fisher Scientific) were cleaned in oxygen plasma 
(Harrick Plasma) before spin coating. After the exposure to the oxygen plasma the glass 
surface was hydroxyl-terminated. Hydroxyl-terminated, but roughened glass substrates 
were prepared by reactive ion etching (Trion Technology) using the following conditions: 5 
sccm O2, 10 sccmCF4, 100 WRF power, 30 mTorr total pressure. For the Vectabond 
treatment of the glass, plasma-cleaned glass coverslips were immersed into Vectabond 
reagent solution (Vector Laboratories, 20 μL/ml in acetone) for 5 min.28 The coverslips 
were then taken out of the Vectabond solution and rinsed with molecular biology grade 
water (Thermo Scientific) for 30 s and dried under nitrogen. The Vectabond treatment 
changes the surface functionality from hydroxyl- to amine-terminated. All solvents used in 
these experiments were of spectroscopic grade and were used as received. Blank tests 
were always performed before nanocar deposition to test for fluorescence impurities from 
the solvent and the substrate. Single-molecule fluorescence images were taken with a 
home-built confocal microscope consisting of a 514 nm Ar+ laser (Modu-Laser) as the 
excitation source, an  inverted microscope (Zeiss Axiovert 200), a xyz piezo scanning stage 
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(Physik Instrumente), an oil-immersion objective lens (Zeiss Fluar), and two avalanche 
photodiodes (Perkin-Elmer). The nanocars were excited using circularly polarized light 
with a power of 500 nW. Fluorescence was separated from the laser excitation using 
appropriate dichroic and notch filters. The fluorescence images were formed by scanning 
the sample across the focused laser beam with the scanning stage. Image dimensions were 
10 μm  10 μm and consisted of 128  128 pixels with an integration time of 1ms/pixel. 
The S/N ratio was comparable for all substrates, suggesting that the results were not 
influenced by different degrees of fluorescence quenching through nanocar surface 
interactions. All experiments were repeated at least three times starting every 
measurement with the preparation of the substrates, nanocar deposition, and fluorescence 
imaging. The average diffusion constants obtained for each measurement were used to 
calculate the reported errors. 
Supporting Information. 1H and 13C NMR spectra of new compounds, time-lapse 
fluorescent images, and AFM images of the different substrates. 
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Chapter 3 
Toward Chemical Propulsion: Synthesis of 
ROMP−Propelled Nanocars 
Note: This chapter was copied in its total from a paper that I coauthored.1 Reprinted with 
permission from reference 1. Copyright 2011 American Chemical Society. 
3.1. Introduction 
In the current trend of miniaturization of devices, science and engineering on the 
nanoscale offers new possibilities for the design and synthesis of functional materials.2 In 
contrast to the “top-down” approach that is currently reaching its limits, nanoscale 
engineering is also driven by a “bottom-up” approach. Nanomachines are promising new 
entities that are designed to exhibit controlled mechanical motion resembling their 
macroscopic analogues.3−5 Among the most important tasks for molecular machines is the 
directed motion and transport of nanocargo. 
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We have recently developed a family of nanovehicles that resemble their 
macroscopic analogues, with the goal of transporting nanocargo in a controlled manner on 
surfaces.6,7 These so-called nanocars are composed of a chassis connected to axles 
terminated by molecular wheels. The first generation nanocar bearing C60 wheels showed 
thermally activated translational motion and pivoting on a gold surface.8,9 The translational 
motion occurred perpendicular to the axles. The directionality of the translation was 
possible due to the rolling action of the molecular wheels. However, in order to obtain 
unidirectional motion, the nanocar must consume energy from an external source since 
latent thermal energy only leads to two-dimensional Brownian motion.3  
The goal of the present work is to synthesize a nanomachine that can convert 
energy inputs into controlled unidirectional motion on a surface. In the first examples of 
such control, the electric field gradient of a scanning tunneling microscope tip was 
successfully used to attract a nanocar in a forward-rolling motion.8 Also, a nanocar 
incorporating a light-powered Feringa motor10 and a diazobenzene-based nanoworm11 
have already been described. However, investigation of other sources of energy, such as the 
thrust that can be developed from the energy released during a chemical reaction, would 
permit the synthesis of a family of nanovehicles that can be operated using various stimuli. 
For example, biological nanomachines such as myosin or ATP synthase commonly use the 
energy liberated by a chemical reaction (generally the hydrolysis of ATP) to bias Brownian 
motion into unidirectional motion. Alternatively, artificial chemically powered nanomotors 
working in solution have recently been described.12 These nanomotors are bimetallic 
nanorods that use the catalytic dismutation of hydrogen peroxide for propulsion in 
solution.  
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Inspired both by nature and artificial systems, in this work, we have investigated the 
functionalization of p-carborane-wheeled nanocars with Ru based metathesis catalysts for 
potential propelling by a ring-opening metathesis polymerization (ROMP).  
 
Figure 3.1.1 Ru-based metathesis catalyst nanocars 1 and 2. Every vertex of the carborane 
wheel is BH except the darkened sites, where the outer (para) is CH and the inner (ipso) is 
alkynyl-substituted C. 
 
Three main methods have been previously explored to attach a metathesis catalyst 
to a support.13 Permanent binding can be achieved by exchange of the anionic ligands or via 
modification of the N-heterocyclic carbene (NHC) ligand, whereas temporary attachment 
can be accomplished by a benzylidene moiety. In this report, we present the synthesis and 
catalytic activity toward ROMP of two modified Hoveyda−Grubbs metathesis catalysts, 1 
and 2, bound to a carborane-wheeled nanocar by a benzylidene moiety (Figure 3.1). By 
feeding the nanocar with a cyclic strained alkene such as norbornene, a ROMP should occur 
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on the surface and the energy liberated might provide the thrust to propel the nanocar 
(Figure 3.2). 
 
Figure 3.2.1 Proposed propulsion scheme for a nanocar composed of four wheels (blue) 
connected to a chassis (green) by two axles (red), and bearing a ruthenium-based ROMP 
catalyst. By addition of norbornene, a ROMP should occur at the ruthenium site leading to a 
polymer growth on one end of the nanocar. In the process, the energy liberated might 
propel the nanocar. Concurrently, the ruthenium catalyst and the nanocar will move away 
from each other (blue arrows). 
 
3.2. Results and Discussion 
3.2.1. Design and Synthesis 
The syntheses of nanocars 1 and 2 are based on a modular approach using a styryl-
substituted nanocar as a common intermediate. To synthesize the precursor of the 
isopropoxy styryl fragment, 5-iodosalicylaldehyde was alkylated with 2-iodopropane in the 
presence of Cs2CO3 to give 3. A Sonogashira coupling between iodide 3 and 
trimethylsilylacetylene (TMSA) gave protected alkyne 4 which, after deprotection with 
K2CO3 in MeOH, afforded 5 (Scheme 3.1). 
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Scheme 3.1.1 Synthesis of isoproxy benzaldehyde 5. 
 
The nanocar moiety was first assembled by a statistical coupling between alkyne 614 
and axle 7.14 Coupling of the resultant iodide nanocar 8 with alkyne 5 afforded aldehyde 
nanocar 9 in good yield. Finally, styryl-substituted nanocar 10 was obtained by olefination 
of aldehyde 9 under conventional Wittig conditions (Scheme 3.2). 
 Scheme 3.2.1 Synthesis of styryl-substituted nanocar 10. 
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With styryl-substituted nanocar 10 in hand, we proceeded to the preparation of the 
catalysts using a ligand exchange procedure (Scheme 3.3).15 Nanocar 10 was treated with 
Grubbs first-generation 1116 or second-generation catalyst 1217 in CH2Cl2 at 40 °C for 2 h in 
presence of CuCl as a phosphine scavenger. 1H NMR analysis of the crude reaction indicated 
the formation of only one benzylidene-containing species. The other major compound in 
the mixture was unreacted nanocar 10. After chromatographic purification on silica gel, 
phosphine-containing complex 1 was obtained in 63% yield whereas NHC-substituted 
complex 2 was obtained in 53% yield. Although the complexes were stored in a glovebox, 
they were both air- and moisture-stable. A catalyst solution prepared in CDCl3 under 
ambient conditions did not show changes by 1H NMR after 3 days.  
 
Scheme 3.3.1 Final assembly of nanocars 1 and 2. 
 
NMR spectroscopic data were consistent with a typical Hoveyda−Grubbs Ru 
complex.18 The alkylidene proton in the phosphine-containing complex 1 was observed in 
the 1H spectrum as a doublet at 17.40 ppm with JPH = 4.4 Hz, whereas the benzylidene 
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carbene 13C signal was observed at 277.4 ppm. The presence of the phosphine ligand was 
confirmed by the 31P NMR signal observed at 60.16 ppm. In the case of the NHC substituted 
complex 2, the benzylidene proton was observed in the 1H spectrum as a broad singlet at 
16.61 ppm and the benzylidene carbene 13C resonated at 295.0 ppm. The isopropoxy 
methine protons were observed at 5.33 and 4.96 ppm for 1 and 2, respectively.  
3.2.2. Catalytic Activity 
The catalytic activity of 1 and 2 toward ROMP of 1,5-cyclooctadiene (cod) was tested 
according to the standard procedure developed by Grubbs (Figure 3.3).19,20 In that system, 
cod was selected partially due to its relatively slow polymerization rate, compared to more 
highly strained cyclic olefins such as norbornene, which facilitates monitoring of the 
reaction by NMR spectroscopy.  
 
Figure 3.3.1 ROMP activity of 1 and 2 versus their unsubstituted analogues 13 and 14. 
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Only 5% conversion was observed using the phosphine-containing complex 1 as 
catalyst during the 60 min that the reaction was monitored. Low activity was expected for 
1, however, given that its parent Hoveyda−Grubbs catalyst 13 exhibits 4% conversion 
under those conditions. On the other hand, nearly complete conversion was observed with 
the NHC substituted complex 2 when the first spectrum was taken at 3 min. This complex 
had comparable activity to its parent catalyst 14. 
The activation of oxygen-chelated ruthenium catalysts by electron-withdrawing 
groups has been well established.21 One of the most prominent examples is the nitro-
substituted complex 15 (Table 3.1) reported by Grela and co-workers. The catalytic activity 
of 15 toward a variety of olefin metathesis processes is remarkably higher than that of 
14.22 They reasoned that the electron-withdrawing nitro group would weaken the iPrO−Ru 
chelation and therefore facilitate initiation of the catalytic cycle. Comparison of NMR data 
between 15 and its parent catalyst 14 further supports their conclusion (Table 3.1).  
 δ (ppm) in CDCl3 
 
cmpd Ca Ha Cb Hb 
2 76.2 4.96 295.0 16.61 
14 74.9 4.89 296.8 16.56 
15 77.6 4.98 291.2 16.47 
Table 3.1.1 Comparison of NMR data of complexes 2, 14, and 15. 
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The iPrO methine proton (Ha) and carbon (Ca) of 15 are shifted downfield compared 
to 14, whereas the benzylidene carbene carbon (Cb) and proton (Hb) are shifted upfield. 
Similarly, the iPrO carbon and proton signals of NHC-substituted nanocar 2 are shifted 
downfield, whereas its benzylidene carbene carbon is shifted upfield, although the 
benzylidene proton is shifted downfield. Therefore, it is possible that the sp-linked nanocar 
chassis slightly decreases the availability of the isopropoxy-ether lone pair to bind the 
ruthenium and thereby might cause a subtle enhancement of the catalytic activity of 2 with 
respect to 14, though the data obtained are too close to make any conclusive assessments. 
Due to the low conversion observed with cod, the catalytic activity of phosphine 
containing nanocar 1 toward ROMP was also tested with a more reactive substrate 
(Scheme 3.4). With norbornene, a highly viscous mixture was obtained within a few 
minutes, indicating a high degree of polymerization. According to the ratio of the integrals 
of the vinyl protons in the ring-opened polynorbornene, the polymer obtained was, as 
expected, 
predominantly trans (84%). 
 
Scheme 3.4.1 ROMP of norbornene catalyzed by 1. 
 
These results show that both norbornene and 1,5- cyclooctadiene might be usable as 
chemical fuels for the ROMP-propelled motion of nanocars 1 and 2 on a surface. Designing 
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the imaging reaction chamber remains a challenge, however. We further tried, 
unsuccessfully, to prepare the nanocar such that the Ru catalyst would remain permanently 
bound to the nanocar during and after polymerization.23  
3.3. Conclusions 
In summary, we have synthesized potentially chemically powered nanocars based 
on olefin metathesis catalysts. We demonstrated that stable yet highly active modified 
Hoveyda−Grubbs catalyst nanocars 1 and 2 can be prepared using a ligand exchange 
process on the benzylidene moiety. Their high activity toward ROMP in solution makes 
them good candidates for surface-initiated ROMP that will permit evaluation of polymer 
growth to propel the motion of the nanocar.  
3.4. Experimental Section 
General Methods. 1H NMR and 13C NMR spectra were recorded at 400 or 500 and 
100 or 125 MHz, respectively. Chemical shifts () are reported in ppm from residual signal 
of CDCl3 ( 7.26 ppm). 31P NMR spectra were recorded at 202 MHz. Chemical shifts of the 
phosphorus resonances were determined relative to 85% phosphoric acid as the external 
standard (H3PO4:  0.0 ppm). All MALDI-TOF experiments were performed using alpha 
cyano-4-hydroxy-cinnamic acid as the matrix in positive ion mode (+eV). FTIR spectra 
were recorded using a Nicolet FTIR Infrared Microscope with ATR objective with 2 cm-1 
slit. Melting points of compounds 3, 4 and 5 were recorded on a MEL-TEMP Electrothermal 
melting point apparatus. The other solid compounds did not melt below 200 °C. Reagent 
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grade tetrahydrofuran (THF) was distilled from sodium benzophenoneketyl. Triethylamine 
(Et3N) and dichloromethane (CH2Cl2) were distilled from CaH2 under N2 atmosphere. THF 
and Et3N were degassed with a stream of argon for 30 min before being used in 
Sonogashira coupling reactions. cis,cis-1,5-Cyclooctadiene was distilled from CaH2 under a 
nitrogen atmosphere. Trimethylsilylacetylene (TMSA) was donated by FAR Research Inc. or 
Petra Research. All other chemicals were purchased from commercial suppliers and used 
without further purification. The reactions were conducted under nitrogen atmosphere. 
Flash column chromatography was performed using 230-400 mesh silica gel from EM 
Science for all compounds except for nanocars 1 and 2, which were purified using 40-63 
µm Geduran silica gel 60 from EMD Chemicals. Thin layer chromatography (TLC) was 
performed using aluminum plates pre-coated with silica gel 60 F254 0.20 mm layer 
thickness purchased from Sigma-Aldrich. The syntheses of 614 and 714  were performed 
according to reported protocols. 
General Procedure for the Coupling of a Terminal Alkyne with an Aryl Iodide 
Using a Palladium-Catalyzed Cross-Coupling (Sonogashira) Protocol. To an oven-dried 
round-bottom flask or Schlenk tube equipped with a magnetic stir bar were added the aryl 
halide, the terminal alkyne, PdCl2(PPh3)2 (ca. 5 mol% per aryl halide) and CuI (ca. 10 mol% 
per aryl halide). A solvent system of THF:Et3N 3:1 was well-degassed under argon for 30 
min prior to addition to the reaction mixture. Upon completion, the reaction was quenched 
with a saturated solution of NH4Cl. The organic layer was then diluted with CH2Cl2 (2) and 
washed with water or saturated NH4Cl (1). The combined aqueous layers were extracted 
with CH2Cl2 (2). The combined organic layers were dried over MgSO4, filtered, and the 
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solvent was removed from the filtrate in vacuo to afford the crude product, that was 
purified by column chromatography. 
Compound 3. A Schlenk tube equipped with a magnetic stir bar was charged with 5-
iodosalicyladehyde (823 mg, 3.32 mmol), cesium carbonate (2.14 g, 6.64 mmol), and DMF 
(30 mL). Then isopropyl iodide (1.2 mL, 11.6 mmol) was added and the mixture stirred 
overnight at 50 °C. The reaction was quenched with water (50 mL), and then was extracted 
with diethyl ether (50 mL). The organic layer was washed with water (50 mL 5). After 
drying the organic layer with MgSO4, the solvent was removed in vacuo to give 3 as a white 
solid (824 mg, 86%): mp 54−56 °C. FTIR (neat) 3338, 3092, 3059, 2977, 2860, 2758, 2545, 
2482, 2362, 2053, 1877, 1831, 1780, 1677, 1609, 1582, 1463, 1423, 1404, 1390, 1382, 
1372, 1352, 1335, 1272, 1237, 1183, 1142, 1105 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  
10.35 (s, 1H), 7.08 (d, 1H, J = 2.4 Hz), 7.76 (dd, 1H, J1 = 8.8 Hz, J2 = 2.4 Hz), 6.77 (d, 1H, J = 
8.8 Hz), 4.65 (sep, 1H, J = 6.0 Hz), 1.39 (d, 6H, J = 6.0 Hz); 13C NMR (125 MHz, CDCl3, ppm)  
188.8, 160.3, 144.1, 137.2, 127.6, 116.6, 82.8, 71.7, 22.1, 1.2; EI-HRMS m/z calcd for 
C10H11IO2 289.9804, found 289.9803. 
Compound 4. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were 3 (824 mg, 2.84 mmol), Pd(PPh3)2Cl2 (60 mg, 0.085 mmol), CuI (32 
mg, 0.17 mmol), THF (18 mL), and Et3N (6 mL). TMSA (0.81 mL, 5.68 mmol) was added via 
syringe and the mixture was stirred at rt overnight. The residue was purified by flash 
column chromatography (silica gel, 40% CH2Cl2 in hexanes) to provide 4 as a light-yellow 
solid (715 mg, 2.74 mmol, 97%): mp 56−58 °C. FTIR (neat) 3655, 3334, 3047, 2963, 2900, 
2876, 2765, 2512, 2325, 2188, 2153, 2011, 1979, 1943, 1879, 1799, 1678, 1603, 1569, 
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1482, 1410, 1393, 1384, 1374, 1354, 1273, 1247, 1217, 1178, 1159, 1138, 1115, 1101 
cm−1; 1H NMR (500 MHz, CDCl3, ppm)  10.39 (s, 1H), 7.90 (d, 1H, J = 2.4 Hz), 7.56 (dd, 1H, 
J1 = 8.8 Hz, J2 = 2.4 Hz), 6.89 (d, 1H, J = 8.4 Hz), 4.66 (sep, 1H, J = 6.0 Hz), 1.38 (d, 6H, J = 6.0 
Hz), 0.22 (s, 9H); 13C NMR (125 MHz, CDCl3, ppm)  189.3, 160.4, 138.9, 132.4, 125.5, 115.6, 
113.9, 103.91, 93.8, 71.5, 22.1, 0.11; EI-HRMS m/z calcd for C15H20O2Si 260.1233, found 
260.1228. 
Compound 5. A 50 mL round-bottom flask equipped with a magnetic stir bar was 
charged with 4 (80 mg, 0.307 mmol), MeOH (5 mL), and THF (5 mL). K2CO3 was added 
(100 mg, 1.00 mmol) and the mixture was stirred at room temperature for 2 h. The 
reaction was quenched with 15% NH4Cl (20 mL) and then extracted with CH2Cl2 (20 mL 
2). The combined organic fractions were dried with MgSO4 and evaporated in vacuo. The 
residue was purified by column chromatography (silica gel, 40% CH2Cl2 in hexanes) to 
provide 5 as a white solid (54 mg, 0.29 mmol, 94%): mp 84−85 °C. FTIR (neat) 3343, 3258, 
3046, 2988, 2491, 2912, 2874, 2764, 2101, 1911, 1822, 1680, 1602, 1565, 1485, 1450, 
1417, 1388, 1351, 1335, 1282, 1250, 1212, 1183, 1164, 1131, 1113, 1104 cm−1; 1H NMR 
(500 MHz, CDCl3, ppm)  10.41 (s, 1H), 7.93 (d, 1H, J = 2.0 Hz), 7.60 (dd, 1H, J1 = 9.0 Hz, J2 = 
2.0 Hz), 6.93 (d, 1H, J = 9.0 Hz), 4.69 (sep, 1H, J = 6.0 Hz), 3.01 (s, 1H), 1.40 (d, 6H, J = 6.5 
Hz); 13C NMR (125 MHz, CDCl3, ppm)  189.3, 160.7, 139.2, 132.5, 125.6, 114.5, 114.1, 82.6, 
76.9, 71.6, 22.1; EI-HRMS m/z calcd for C12H12O2 188.0837, found 188.0838. 
Compound 8. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 624 (257 mg, 0.43 mmol), 724 (477 mg, 0.72 mmol), 
PdCl2(PPh3)2 (25 mg, 36.0 µmol), CuI (14.0 mg, 72 µmol), THF (45 mL), and Et3N (15 mL) at 
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rt overnight. The crude product was purified by column chromatography (silica gel, 20% 
CH2Cl2 in hexanes) to yield 8 as a yellow solid (154 mg, 32%). FTIR (neat) 3062, 2825, 
2854, 2611, 2360, 2212, 2212, 1726, 1595, 1504, 1487, 1463, 1411, 1362, 1281, 1221, 
1140, 1064, 1042 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.74 (s, 1H), 7.47 (d, 1H, J = 1.0 Hz), 
7.41 (s, 1H), 7.23 (d, 1H, J = 8.0 Hz), 7.14 (dd, 1H, J1 = 8.0 Hz, J2 = 1.5 Hz), 7.06 (d, 1H, J = 6.5 
Hz), 3.99 (s, 6H),  3.20−1.60 (br m, 44H); 13C NMR (125 MHz, CDCl3) δ 154.3, 142.0, 135.5, 
135.4, 132.3, 131.2, 128.6, 126.7, 126.3, 124.9, 124.0, 122.2, 115.9, 115.8, 113.8, 113.2, 
99.7, 92.3, 92.1, 92.0, 91.5, 91.21, 91.17, 90.9, 88.1, 80.7, 78.1, 78.0, 77.2, 76.5, 69.7, 69.3, 
69.1, 60.9, 60.7, 60.5, 56.7, 56.6; MALDI-TOF MS (+eV) m/z calcd for C40H57B40IO2 1129.2, 
found 1129.6. 
Compound 9. See the general procedure for the Pd/Cu Sonogashira coupling 
reaction. The materials used were 8 (84 mg, 0.074 mmol), 5 (28 mg, 0.15 mmol), 
PdCl2(PPh3)2 (5.0 mg, 7.1 µmol), CuI (2.5 mg, 13.1 µmol), THF (10 mL), and Et3N (10 mL) at 
rt overnight. The crude product was purified by column chromatography (silica gel, 5% 
EtOAc in hexanes) to yield 9 as a yellow solid (80 mg, 91%). FTIR (neat) 3063, 2978, 2864, 
2610, 2213, 1688, 1603, 1504, 1464, 1412, 1386, 1271, 1221, 1184, 1138, 1109, 1063, 
1043, 1007 cm−1; 1H NMR (400 MHz, CDCl3, ppm)  10.48 (s, 1H), 8.03 (d, 1H, J = 2.4 Hz), 
7.68 (dd, 1H, J = 8.8 Hz, J = 2.0 Hz), 7.49 (s, 1H), 7.48 (d, 1H, J = 1.6 Hz), 7.44 (s, 1H), 7.23 (d, 
1H, J = 8.4 Hz), 7.14 (dd, 1H, J1 = 8.0 Hz, J2 = 1.6 Hz), 7.07 (m, 2H), 7.03 (d, 1H, J = 9.2 Hz), 
4.77 (sep, 1H, J = 6.0 Hz), 4.00 (s, 6H), 3.20−1.60 (br m, 44H), 1.45 (d, 6H, J = 6.5 Hz); 13C 
NMR (125 MHz, CDCl3) δ 189.2, 160.9, 154.28, 154.26, 138.8, 135.8, 135.5, 135.43, 135.39, 
132.47, 132.34, 131.18, 130.49, 127.90, 127.86, 126.7, 125.8, 125.7, 124.04, 124.00, 123.96, 
122.2, 115.8, 114.9, 114.2, 113.7, 113.4, 95.1, 92.4, 92.3, 92.1, 91.5, 91.3, 91.2, 90.9, 88.0, 
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86.2, 78.1, 78.0, 77.3, 71.7, 69.4, 60.5, 56.7, 29.9, 22.2; MALDI-TOF MS (+eV) m/z calcd for 
C52H68B40O4 1189.5, found 1189.8. 
Compound 10. MePPh3Br (217 mg, 0.61 mmol) was dried at 60 °C in vacuo for 2 h 
in a 50 mL round-bottom flask equipped with a magnetic stir bar. THF was added (20 mL) 
and the resultant suspension was cooled to 0 °C. BuLi (2.5 M in hexane, 0.24 mL, 0.61 
mmol) was added dropwise and the mixture was stirred for 30 min at 0 °C. A yellow 
solution was obtained. Only 5.0 mL of this solution were transferred via syringe to a 
solution of compound 9 (120 mg, 0.101 mmol) in THF (10 mL) cooled to 0 °C. The mixture 
was allowed to warm at rt and stirred overnight. The solvent was removed. The crude 
product was purified by column chromatography (silica gel, 15% CH2Cl2 in hexanes) to 
yield 10 as a yellow solid (84 mg, 69%). FTIR (neat) 3062, 2964, 2612, 2211, 1689, 1600, 
1504, 1464, 1411, 1385, 1279, 1242, 1221, 1111, 1064, 1043 cm−1; 1H NMR (500 MHz, 
CDCl3) δ 7.70 (d, 1H, J = 2.0 Hz), 7.49 (d, 1H, J = 0.5 Hz), 7.48 (d, 1H, J = 1.0 Hz), 7.44 (s, 1H), 
7.39 (dd, 1H, J1= 8.6 Hz, J2 = 2.0 Hz), 7.23 (dd, 1H, J1 = 8.0 Hz, J2 = 0.5 Hz), 7.14 (dd, 1H, J1 = 
8.1 Hz, J2 = 1.6 Hz), 7.09−7.00 (m, 3H), 6.88 (d, 1H, J = 8.7 Hz), 5.85 (dd, 1H, J1 = 17.8 Hz, J2 = 
1.1 Hz), 5.33 (dd, 1H, J1 = 11.2 Hz, J2 = 1.2 Hz),  4.63 (sep, 1H, J = 6.0 Hz), 4.00 (s, 6H),  
3.20−1.60 (br m, 44H), 1.39 (d, 6H, J = 6.0 Hz); 13C NMR (125 MHz, CDCl3) δ 156.1, 154.3, 
135.8, 135.5, 135.4, 132.6, 132.3, 131.3, 131.2, 130.6, 128.3, 126.7, 126.4, 125.3, 124.0, 
123.9, 123.8, 122.2, 115.84, 115.80, 115.3, 114.5, 113.7, 113.6, 113.5, 96.7, 92.2, 91.2, 91.0, 
88.0, 85.4, 78.2, 78.0, 77.8, 71.0, 69.6, 69.4, 60.6, 56.7, 22.4; MALDI-TOF MS (+eV) m/z calcd 
for C53H70B40O3 1187.6, found 1187.8. 
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Nanocar Catalyst 1. A 10 mL round-bottom flask equipped with a magnetic stir bar and 
condenser was charged with Ru complex 1116 (11.5 mg, 13.9 μmol) and CuCl (4.0 mg, 40.0 
μmol). Then CH2Cl2 (0.5 mL) was added, immediately followed by addition of a solution of 
nanocar 10 (15.0 mg, 12.6 μmol) in CH2Cl2 (2.5 mL). The resulting solution was stirred at 
40 °C for 2 h. The solvent was removed in vacuum, and the residue was purified (Geduran 
silica gel, 40% then 70% CH2Cl2 in hexanes) to afford 1 as a brownish solid (14.0 mg, 63%). 
Five milligrams of starting material 10 was recovered: FTIR (neat) 3059, 2928, 2852, 2611, 
2361, 1688, 1594, 1504, 1450, 1411, 1386, 1262, 1221, 1181, 1101, 1063, 1043, 1008 
cm−1; 1H NMR (500 MHz, CDCl3) δ 17.40 (d, 1H, JPH = 4.4 Hz), 7.91 (d, 1H, J = 2.0 Hz), 7.79 
(dd, 1H, J1 = 8.6 Hz, J2 = 2.0 Hz), 7.50 (s, 1H), 7.48 (d, 1H, J = 1.0 Hz), 7.46 (s, 1H), 7.23 (d, 1H, 
J = 8.0 Hz), 7.13 (m, 2H), 7.07 (d, 2H, J = 3.0 Hz), 5.33 (septet, 1H, J = 6.0 Hz), 4.00 (s, 6H), 
3.20−1.70 (br m, 83H); 13C NMR (125 MHz, CDCl3) δ 277.4, 154.29, 154.26, 153.4, 144.0, 
135.9, 135.7, 135.5, 132.9, 132.5, 132.3, 131.2, 126.7, 126.1, 125.8, 125.7, 125.6, 124.04, 
123.96, 123.93, 122.2, 117.2, 115.8, 113.8, 113.7, 113.4, 94.9, 92.4, 92.2, 92.1, 91.3, 91.2, 
90.9, 88.0, 86.7, 78.1, 78.0, 77.8, 76.7, 71.7, 69.7, 69.5, 69.3, 60.5, 56.6, 36.1, 35.9, 30.3, 29.9, 
28.0, 27.9, 26.4, 22.4, 22.2; 31P NMR (202 MHz, CDCl3) δ 60.16 (s). It was not possible to 
obtain mass spectrometry characterization of this compound; MALDI-TOF, ESI, and EI 
methods were attempted. 
Nanocar Catalyst 2. A 10 mL round-bottom flask equipped with a magnetic stir bar 
and condenser was charged with Ru complex 1217 (7.5 mg, 8.8 μmol) and CuCl (4.0 mg, 
40.4 μmol). Then CH2Cl2 (0.5 mL) was added, immediately followed by addition of a 
solution of nanocar 10 (10.0 mg, 8.0 μmol) in CH2Cl2 (2.5 mL). The resulting solution was 
stirred at 40 °C for 2 h. The solvent was removed in vacuum, and the residue was purified 
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(Geduran silica gel, 40% then 60% CH2Cl2 in hexanes) to afford 2 as an olive green solid 
(7.0 mg, 53%). One milligram of starting material 10 was recovered: FTIR (neat) 3054, 
2966, 2924, 2856, 2611, 2210, 1950, 1725, 1593, 1488, 1463, 1412, 1385, 1262, 1220, 
1162, 1134, 1102, 1063, 1040 cm−1; 1H NMR (500 MHz, CDCl3) δ 16.61 (s, 1H), 7.70 (dd, 1H, 
J1 = 8.5 Hz, J2 = 2.0 Hz), 7.49 (s, 1H), 7.48 (d, 1H, J = 1.0 Hz), 7.42 (s, 1H), 7.23 (d, 1H, J = 8.5 
Hz), 7.15 (dd, 1H, J1 = 8.5 Hz, J2 = 2.0 Hz), 7.11−7.07 (m, 7H), 6.86 (d, 1H, J = 9.0 Hz), 4.96 
(septet, 1H, J = 6.0 Hz), 4.19 (s, 4H), 4.00 (s, 6H), 3.20−1.70 (br m, 62H), 1.31 (d, 6H, J = 6.0 
Hz); 13C NMR (125 MHz, CDCl3) δ 295.0, 210.6, 154.3, 153.0, 145.4, 139.3, 135.8, 135.6, 
133.2, 132.4, 131.2, 129.7, 126.7, 126.0, 125.64, 125.55, 124.14, 124.07, 123.9, 122.2, 117.0, 
115.8, 113.7, 113.4, 95.1, 92.4, 92.24, 92.18, 91.5, 91.3, 91.2, 91.0, 88.0, 86.1, 78.1, 78.0, 
77.8, 76.2, 69.7, 69.5, 69.3, 60.6, 60.5, 56.7, 51.8, 29.9, 21.3. It was not possible to obtain 
mass spectrometry characterization of this compound. MALDI-TOF, ESI, and EI methods 
were tried. 
ROMP of 1,5-cyclooctadiene.19 CD2Cl2 was freeze/pump/thawed three times. 
cis,cis-1,5-Cyclooctadiene was distilled over CaH2 immediately prior the polymerization 
reaction. As reported by Grubbs,19 in our experience, aged cyclooctadiene gave 
considerably lower rates. 1H NMR spectra were collected at 500 MHz. Inside a glovebox, an 
NMR tube with a septum/screw cap was charged with catalyst solution (0.40 μmol) and 
CD2Cl2 to give a total volume of 0.80 mL. The solution was equilibrated at 30 °C in the NMR 
probe. The sample was then ejected to add cis,cis-1,5-cyclooctadiene (50 μL, 0.40 mmol) via 
syringe. A series of spectra were collected over an appropriate period of time. The degree 
of conversion to polymer was determined by comparing the ratio of the integrals of the 
methylene protons in the starting material, δ 2.36 (m) with those in the product, δ 2.09 br 
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(m), δ 2.04 (br m). The integration that 1 and 2 exhibit in this region was neglected since a 
1000:1 ratio of cis,cis-1,5-cyclooctadiene/catalyst was used. 
Supporting Information. 1H and 13C NMR spectra of new compounds and tables of 
ROMP results. 
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3.6. Experimental Contributions Section 
My contributions to the experimental work described in this chapter are the synthesis 
and characterization of all the molecules, and the study of the catalytic activity of the 
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nanocars. Guillaume Vives conceived of the project and synthesized nanocar intermediates 
3, 4, 5, and 8.   
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Chapter 4 
A Polymerization-Propelled 
‘Nanosubmarine’: Synthesis and Diffusion 
Studies 
4.1. Introduction 
The synthesis of micro- and nano-sized motors has attracted much interest in 
recent years.1 Concomitantly, a number of chemically propelled nanomotors have 
been developed to operate in solution.2 Interesting examples of these include 
bimetallic nanorods that use the catalytic dismutation of H2O2 to induce 
translational movement,3 and silica particles equipped with a H2O2 
disproportionation catalyst.4 In these systems, small by-product molecules are 
produced during the propulsion. 
An attractive alternative is to explore in synthetic systems the potential of a 
polymerization process to propel motion at the nanoscale, given that this 
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mechanism of propulsion is already present in nature. For example, the movement 
of the bacterium listeria monocytogenes is driven by the polymerization of actin.5 
Indeed, it was recently demonstrated that gold-silica Janus particles functionalized 
with a ring-opening metathesis polymerization (ROMP) catalyst can be propelled by 
a polymerization process.6 Upon addition of the cyclic olefin norbornene, the 
diffusion constant of the particles increased up to 70%. These particles, however, 
are approximately 500 nm in diameter. Similarly, the size of the other nanomotors 
described above spans from several hundreds of nanometers to a few microns. 
Hence, to the best our knowledge, chemically propelled synthetic nanomotors that 
are truly molecule sized have not been reported.  
The purpose of the present work was to investigate if chemical propulsion 
through a ROMP process can be achieved at the molecular level in the solution 
phase. Our hypothesis was that the diffusion constant of a ROMP catalyst would 
increase during catalysis. One method to monitor the diffusion of molecules in 
solution is fluorescence correlation spectroscopy (FCS).7 Therefore, to test our 
hypothesis using FCS to monitor movement, it was necessary to prepare a 
fluorescent ROMP catalyst (Figure 4.1).   
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Figure 4.1. Proposed propulsion scheme for a fluorescent ROMP catalyst. Upon 
addition of cyclic olefin, a ROMP process should occur and the energy released may 
be sufficient to propel the catalyst, thereby increasing its diffusion constant (D) from 
D0 to Dromp, as detected using FCS. A decrease in lag time in the autocorrelation 
curve denotes an increase in diffusion constant.  
    
A number of different types of ROMP catalysts have been developed; the Ru-
based Hoveyda-Grubbs type (Figure 4.2) was selected for this study, due to its high 
catalytic activity and relatively higher stability toward air/moisture when compared 
to other types of catalyst.8  
As described in section 3.1 of the previous chapter, there are three main 
approaches commonly used to functionalize a Hoveyda-Grubbs catalyst.9 Of those, 
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functionalization at the N-heterocyclic carbene (NHC) ligand is the most widely 
used, since the NHC is not exchanged during the ROMP process, thereby providing 
permanent tagging. For this reason the present work focused on the preparation of 
Hoveyda-Grubbs ROMP catalysts dye-tagged at the NHC ligand.   
4.2. Results and Discussion 
4.2.1. Design and Synthesis 
The initial targets of fluorescently labeled ROMP catalysts are presented in 
Figure 4.2. They feature a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)10 
dye attached to the ruthenium complex through the NHC ligand. It was envisioned 
that catalysts 1 and 2 could be prepared through a ligand exchange reaction 
between the 1st generation Hoveyda-Grubbs catalyst (3)11 and the corresponding 
carbenes of imidazolium salts 4 and 5, respectively. The difference between 1 and 2 
is the distance between the BODIPY core and the catalytic center. The ethynyl 
phenyl spacer of 1 was removed in 2, to evaluate the effect of the alkyne on the 
formation of the NHC carbene. 
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Figure 4.2. Structure of the fluorescent Hoveyda-Grubbs catalysts 1 and 2 and the 
final step of the proposed synthesis. 
 
The synthesis of BODIPY imidazolium salt 4 started with a Sonogashira 
coupling between BODIPY 612 and 4-ethynylbenzyl alcohol13 (Scheme 4.1). The 
resultant benzylic alcohol 7 reacted with PBr3 in presence of catalytic DMF to 
substitute the hydroxyl group with a bromide. Finally, alkylation of the benzylic 
bromide in 8 with 1-methylimidazole afforded 4 in excellent yield. 
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Scheme 4.1. Synthesis of BODIPY imidazolium salt 4.  
 
The synthesis of 5 followed a similar approach (Scheme 4.2). BODIPY 914 was 
treated with PBr3 to give the benzylic bromide 10. Then, imidazolium salt 5 was 
obtained in high yield by alkylation of 10 with 1-methylimidazole.   
 
 96 
 
 
 
Scheme 4.2. Synthesis of BODIPY imidazolium salt 5.  
 
With imidazolium salts 4 and 5 in hand, the formation of the corresponding 
carbenes and subsequent ligand exchange with 3 was investigated (Scheme 4.3). 
Although many of the common methods to generate NHC carbenes14 were tried, in 
all the experiments the imidazolium salts decomposed and no desired product was 
detected. The failed approaches included a two step process in which 4 or 5 were 
initially reacted with the first generation Grubbs catalyst (11)16 expecting to 
produce an intermediate NHC Grubbs catalyst that bears a phosphine ligand. Then a 
second ligand exchange with 2-isopropoxystyrene was attempted to produce the 
desired ether-chelate complex. However, the diazonium salts decomposed and no 
desired product was obtained. 
 
 
 
  
 
 
 
 
Scheme 4.3. Failed syntheses of BODIPY-tagged Hoveyda-Grubbs catalysts. 
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Although the cause for the decomposition of the BODIPY imidazolium salt 
was unclear, it was observed that the decomposition occurred during preparation of 
the NHC carbene. Hence, a new strategy was devised in which no NHC carbene 
would be generated in presence of BODIPY. The new target, 12, was synthesized in 
four straightforward steps from previously reported compounds (Scheme 4.4). 
BODIPY 6 was coupled with 4-ethynylbenzoic acid17 under conventional 
Sonogashira coupling conditions. The crude BODIPY carboxylic acid was esterified 
with pentafluorophenol in the presence of N,N’-dicyclohexylcarbodiimide (DCC) to 
give BODIPY pentafluorophenol ester 13. Separately, Boc-protected Hoveyda-
Grubbs complex 1418 was deprotected with hydrogen chloride. Finally, to obtain 12, 
BODIPY ester 13 was coupled with the catalyst terminal amine through formation of 
an amide bond. 
 98 
 
 
 
Scheme 4.4. Synthesis of BODIPY Hoveyda-Grubbs catalyst 12. 
4.2.2.       Optical Properties 
Since our current FCS setup requires excitation of the molecules with a 514 
or 532 nm laser, it was a prerequisite that the BODIPY catalyst 12 exhibit adequate 
absorption at either of those wavelengths. As depicted in Figure 4.3A, 12 absorbs 
strongly in this region, with its λmax = 504 nm (ε = 72 000 M-1cm-1, in CH2Cl2).  
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Figure 4.3. Absorption and emission spectra of 12 and absorption spectrum of 11. 
A) UV−vis absorption (blue line) and emission (red line) spectra of 12 in CH2Cl2. B) 
UV−vis absorption spectrum of the 1st generation Grubbs catalyst (11) in CH2Cl2.  
 
A second requirement was an acceptable fluorescence quantum yield (ΦF). In 
dichloromethane, the fluorescence quantum yield of 12 was 0.22. This value is 
significantly smaller than the fluorescence quantum yield of the precursor BODIPY 6 
(ΦF = 0.46, in CH2Cl2).19 The drop in the fluorescence of 12 compared to 6 could be 
due to fluorescence resonance energy transfer (FRET). Ru-based metathesis 
catalysts, including Hoveyda-Grubbs type, exhibit absorption bands that span across 
the 500 nm region, where BODIPY emits (Figure 4.3B). Therefore, upon excitation of 
the BODIPY core, the energy could be transferred to the Ru center and then released 
in a nonradiative process. The quenching effect of Ru-based complexes has been 
exploited to do a comparative study of the affinity of the Ru complex toward 
alkanes, alkenes and alkynes.20 The time-dependent fluorescence quenching of dye-
tagged alkanes, alkenes and alkynes was monitored as a function of the association 
 100 
 
 
 
with different Ru-based complexes. Nonetheless, a ΦF = 0.22 is sufficient for FCS 
studies, therefore 12 had sufficient optical properties.  
4.2.3. Catalytic Activity 
The catalytic activity of 12 toward ROMP was evaluated in accordance with 
the standard protocol developed by Grubbs21 (Table 4.1). To carry out that 
polymerization test, an NMR tube with a septum-capped screw cap (model 27093, 
Sigma-Aldrich) was charged with a solution of complex 12 in CD2Cl2. The solution 
was equilibrated at 30 °C in the NMR probe. The monomer, cis,cis-1,5-
cyclooctadiene (cod), was then injected into the NMR tube via syringe after ejecting 
the NMR tube from the instrument. A series of 1H NMR spectra were collected over a 
short period of time. The degree of conversion of cod to polymer was determined by 
comparing the ratio of the integrals of the methylene protons in the starting 
material to those in the product. 
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Table 4.1. ROMP of cod catalyzed by 12. 
  
One of the reasons for choosing cod in the procedure developed by Grubbs 
was its relatively slow polymerization rate when compared to more highly strained 
cyclic olefins such as norbornene. Indeed, 96.8% of the cod had reacted by the time 
the first spectrum was collected at 4.2 min (Table 4.1). The high activity of 12 was 
Time (min) % conversion 
4.2 96.8 
5.2 98.9 
6.4 99.6 
7.4 99.8 
8.6 99.9 
9.6 99.9 
10.8 99.9 
11.8 99.9 
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similar to its parent second generation Hoveyda-Grubbs catalyst (15)22 (Figure 4.4), 
which afforded 98.9% conversion of cod at 4.1 min.20 
 
Figure 4.4. Structure of the second generation Hoveyda-Grubbs catalyst. 
 
In addition to being a highly active catalyst, 12 is stable under inert 
conditions. The catalytic activity of a sample that was stored inside a glove box over 
two months remained unchanged. The high catalytic activity along with the above 
discussed optical properties made 12 an excellent candidate to study the potential 
of a polymerization process to induce motion at the molecular level, using FCS. 
4.2.4. Fluorescence Correlation Spectroscopy  
The solvent plays a crucial role in FCS experiments. It not only provides the 
environment for the diffusion of the molecules under study, but it can drastically 
impact the overall outcome of the experiment, as shown in the present study. 
The first solvent selected for this study was p-xylene, since aromatic solvents 
are widely used in ROMP reactions. In addition, its high boiling point (138 °C) was 
desirable to minimize evaporation during the measurements, given that the current 
experimental setup uses only 40 μL of sample and that volume needs to remain 
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constant for ~ 5 min. Despite intense efforts, however, it was not possible to obtain 
reliable information about the dynamics of 12 in this solvent. The most likely reason 
was the closeness of the refractive index (n) of p-xylene (1.49) to that of glass 
(~1.50). In FCS experiments, the incident laser first passes through the glass of the 
sample holder, and then the instrument tries to focus where the refractive index 
changes. If there is no significant change in refractive index, the laser will not focus 
properly and thereby no consistent data will be obtained. For this reason it was 
necessary to use a solvent with n ≤ 1.45.     
The next solvent selected was isopropyl alcohol (IPA), with n = 1.37. The 
focusing issues were solved, and the conditions were optimized to monitor the 
diffusion of 12 before and after addition of cod. The optimum concentration of 12 
was ~ 2 nM in IPA. Under these conditions, the calculated three-dimensional 
diffusion constant (Dt) was (2.1 ± 0.2)  10-10 m2/s (Figure 4.5). Next, to study the 
effect of a ROMP process on the diffusion of 12, different concentrations of cod were 
added: 0.1 M, 0.5 M, or 1 M. However, there was no change detected in the diffusion 
of 12 upon addition of cod, as shown in Figure 4.5 for 0.1 M cod.    
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Figure 4.5. Autocorrelation curves of 12 as a 2 nM solution in IPA, before (dark 
blue) and after addition of cod (light blue). 
 
Seeking to understand why the Dt of 12 remained unchanged upon addition 
of cod, a polymerization test was conducted under conditions identical to those used 
in the FCS experiments. Using 1H NMR to assess the degree of polymerization, it was 
found that only 14% of the monomer had reacted after 5 min, the typical time 
required to complete the FCS measurements.  
A possible reason for the poor polymerization observed was potential 
decomposition of 12 due to oxygen and/or moisture. Increasing the concentration 
of 12 was not an option since the approximation of single-molecule detection would 
not be valid, so instead the low concentration of 12 was maintained and a non-
fluorescent ROMP catalyst was added to serve as a sacrificial substrate to oxygen 
and/or moisture. The second generation Hoveyda-Grubbs catalyst (15) was chosen, 
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since its catalytic activity is very similar to that of 12. In order to optimize its 
fluorescence detection, the concentration of 12 was increased from 2 nM in the 
initial system to 20 nM, due to the quenching effect of the Hoveyda-Grubbs catalyst 
15 that was discussed in section 4.2. The composition of the new FCS sample was 
therefore: 0.47 mM of 15, 20 nM of 12, and for the polymerization experiments, 0.47 
M of cod.  
As shown in Figure 4.6, the Dt of 12 decreased significantly after addition of 
cod. Two reasons that would account for the decrease would be 1) an increase in the 
particle size due to the growing polymer chain bound to the catalyst, and/or 2) an 
increase in the viscosity of the medium.  
 
Figure 4.6. Autocorrelation curves of 12 as a 20 nM solution in IPA, before (red) 
and after addition of cod (black).  
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To assess the impact of the viscosity increase on the diffusion of 12, the 
diffusion of BODIPY 6 was studied. The FCS sample contained 0.47 mM of 15, ~ 1 
nM of BODIPY 6, and for the polymerization experiments, 0.47 M of cod. As 
expected, the diffusion coefficient of 6 decreased; before adding cod, Dt = (1.42 ± 
0.28) x 10-10 m2/s, but upon addition of cod Dt dropped to (0.75 ± 0.13) x 10-10 m2/s. 
Using these data to correct the diffusion due to the increase in viscosity, there was 
an apparent increase in the diffusion coefficient of 12 during the ROMP process 
(Figure 4.7), but the large standard deviation of the experiments with cod prevented 
the confident rendering of a conclusion. An interesting observation was the 
formation of a polymer film in the sample holder during the FCS measurements. If 
the polymer was precipitating from the solution, it is possible that the heterogeneity 
of the system was the cause of the large variability in the results. For this reason a 
different solvent, in which the polymer would be soluble, was used in the next 
experiments. 
 
 
 
 
Figure 4.7. Effect of adding cod on the diffusion coefficient of 12 in IPA. The data in 
orange was calculated from the data in green after correcting for the viscosity 
change. The error bars correspond to the standard deviation of the data.  
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The solvent selected was 1,2-dichloroethane; halogenated solvents are 
commonly used in ROMP reactions. In addition, its refractive index (1.44) and 
boiling point (84 °C) made it a good candidate for the FCS studies. The sample 
composition was 0.47 mM of 15, 2 nM of 12, and in the polymerization experiments, 
0.47 M of cod. The polymer that formed was highly soluble and the system remained 
homogeneous during the ROMP process. As a result, the standard deviation was 
reduced (Figure 4.8).  
 
Figure 4.8. Effect of adding cod on the diffusion coefficients of 12 and 6 in 1,2-
dichloroethane. The error bars correspond to the standard deviation of the data. 
 
Most importantly, the diffusion of 12 increased upon addition of cod (Table 
4.2) by 20 ± 7%, even without correction for the viscosity increase. The diffusion of 
BODIPY 6 was also studied under these conditions. Although no significant change 
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was observed in its average diffusion, the standard deviation was still considerable 
large and therefore the experiment needs to be repeated to confirm the results. 
Sample 
Dt 
[(μm)2 s-1] 
# of measurements 
BODIPY 6 484 ± 34 6 
BODIPY 6 + cod 472 ± 68 4 
12 404 ± 15 6 
12 + cod 483 ± 25 9 
 
Table 4.2. Effect of adding cod on the diffusion coefficient of 12 and 6 in 1,2-
dichloroethane.  
 
Although the mechanism of propulsion is still unknown, these results show 
that catalyst 12 is indeed propelled by the ROMP process, thereby acting as a 
‘nanosubmarine’. However, there are several items that need to be addressed to 
complete this study. Those include a comprehensive study of the effect of monomer 
concentration, use of more reactive monomers, addition of a ROMP inhibitor, 
characterization of the polymer formed, and study of the propulsion mechanism.  
4.3. Conclusions 
In summary, a fluorescent Hoveyda-Grubbs catalyst (12) was synthesized 
and utilized to explore, via FCS, the potential of a ROMP process to provide a 
molecule with sufficient energy for self-propulsion in solution. The catalytic activity 
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of this complex toward ROMP was found to be similar to that of its non-fluorescent 
analogue 15. In addition, by choosing a suitable solvent (1,2-dichloroethane) and 
catalyst/monomer concentration, preliminary results showed an increase of 20 ± 
7% in the diffusion constant of this nanosubmarine in presence of its fuel, cod.  
These results pave the way toward development of truly nanosized chemically 
propelled molecular machines that operate in the solution phase. 
4.4. Experimental Section 
General Methods. 1H NMR and 13C NMR spectra were recorded at 400 or 
500 and 100 or 125 MHz, respectively. Proton chemical shifts () are reported in 
ppm downfield from tetramethylsilane (TMS). MALDI-TOF of 12 was performed 
using 2-[(2E)-3-(4-tert-butylphenyl)-2-methylprop-2-enylidene]malononitrile 
(DCTB) as the matrix. FTIR spectra were recorded by deposition of the sample on a 
KBr plate from a CH2Cl2 solution using a Nicolet FTIR Infrared Microscope with ATR 
objective with 2 cm−1 slit. All reactions were performed under an atmosphere of 
nitrogen unless stated otherwise. Reagent grade tetrahydrofuran (THF) and diethyl 
ether (Et2O) were distilled from sodium benzophenone ketyl. Triethylamine (TEA) 
and CH2Cl2 were distilled over CaH2. 2,4-Dimethylpyrrole was distilled from CaH2 
under a nitrogen atmosphere. cis,cis-1,5-Cyclooctadiene was distilled from CaH2 
under a nitrogen atmosphere. All other chemicals were purchased from commercial 
suppliers and used without further purification. Flash column chromatography was 
performed using 230−400 mesh silica gel from EM Science, except for catalyst 12, 
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which was purified using 40-63 µm Geduran silica gel 60 from EMD Chemicals. Thin 
layer chromatography was performed using glass plates pre-coated with silica gel 
40 F254 purchased from EM Science. The syntheses of compounds 6,12 4-
ethynylbenzyl alcohol,13 4-ethynylbenzoic acid,17 9,14 and 14,18 were performed 
according to formerly reported protocols. 
General Procedure for the Coupling of a Terminal Alkyne with an Aryl 
Halide Using a Palladium-Catalyzed Cross-Coupling (Sonogashira) Protocol. To 
an oven-dried round-bottom flask or screw cap tube equipped with a magnetic stir 
bar were added the aryl halide, the terminal alkyne, PdCl2(PPh3)2 or PdCl2(PhCN)2 
(ca. 2 mol % per aryl halide), CuI (ca. 4 mol % per aryl halide), and in the case of 
using PdCl2(PhCN)2, also ca. 4 mol % per aryl halide of HP(tert-Bu)3. A solvent 
system of TEA and/or THF was added depending on the substrates. Upon 
completion, the reaction was quenched with a saturated solution of NH4Cl. The 
organic layer was then diluted with diethyl ether or CH2Cl2, and washed with water 
or saturated NH4Cl (1). The combined aqueous layers were extracted with hexanes, 
diethyl ether, or CH2Cl2 (2). The combined organic layers were dried over MgSO4 
and filtered, and the solvent was removed from the filtrate in vacuo to afford the 
crude product, which was purified by column chromatography (silica gel). Eluents 
and other slight modifications are described below for each compound. 
General Procedure for Deprotection of TIPS-Protected Alkynes using 
TBAF. In a round-bottomed flask equipped with a magnetic stir bar, the protected 
alkyne was dissolved in THF ([protected alkyne] = 0.05 − 0.1 M). TBAF in THF (1.0 
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M, 1.1 equiv per alkyne) was added. The mixture was stirred at rt for 0.5 h or until 
the reaction was complete (monitored by TLC). The reaction was quenched with a 
saturated solution of NH4Cl. The organic layer was then diluted with ethyl acetate. 
The organic layer was dried over MgSO4 and filtered, and the solvent was removed 
from the filtrate in vacuo to afford the crude product, which was purified by column 
chromatography (silica gel). 
4-Ethynylbenzyl alcohol.13 See the general procedure for the Pd/Cu 
coupling reaction. A screw cap tube was used. The materials used were 4-
bromobenzyl alcohol (0.280 g, 1.50 mmol), TIPSA (0.50 mL, 2.25 mmol), 
PdCl2(PhCN)2 (57.5 mg, 0.15 mmol), CuI (28.0 mg, 0.15 mmol), HP(tert-Bu)3 (87.0 
mg, 0.30 mmol), TEA (10.0 mL), and THF (10.0 mL) at 70 °C overnight. The residue 
was purified by flash column chromatography in silica gel using 20% ethyl acetate 
in hexanes; the product-containing fractions were combined, concentrated and the 
residue was subjected to the general procedure for the deprotection of TIPS-
protected alkynes. The materials used were the TIPS protected intermediate (349 
mg, 1.2 mmol), and TBAF (1.8 mL, 1.0 M in THF). The mixture was stirred at rt for 3 
h. The crude terminal alkyne was purified in a silica gel column using 30% ethyl 
acetate in hexanes as eluent to yield 4-ethynylbenzyl alcohol (131 mg, 0.99 mmol, 
67%, two steps) as a brown oil. 1H NMR (400 MHz, CDCl3)  7.49 (d, J = 8.0 Hz, 2H), 
7.32 (d, J = 8.0 Hz, 2H), 4.70 (s, 2H), 3.07 (s, 1H). 
BODIPY 7. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were BODIPY 612 (610 mg, 1.35 mmol), 4-ethynylbenzyl alcohol13 
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(269 mg, 2.03 mmol), PdCl2(PPh3)2 (47.4 mg, 0.07 mmol), CuI (26.0 mg, 0.135 
mmol), TEA (20.0 mL), and THF (60.0 mL) at rt overnight. The residue was 
suspended in 35 mL of MeOH. The suspension was heated using an oil bath until the 
mixture started boiling. The heating was then turned off, and the mixture was 
allowed to cool inside the oil bath. The resultant solid was filtered under vacuum 
and washed with cold EtOH. After drying the product in vacuum, BODIPY 7 was 
obtained as an orange solid (556 mg, 1.22 mmol, 91%). FTIR (neat) 3558, 3116, 
3066, 3039, 2954, 2919, 2874.5, 2842, 2786, 2730, 2680, 2347, 2223, 1926, 1619, 
1540, 1501.5, 1466, 1401, 1366, 1298,1266, 1183, 1157, 1086, 1039, 968, 824, 765, 
703 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 8.4 Hz, 2H), 7.56 (d, J = 8.0 Hz, 2H), 
7.38 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.99 (s, 2H), 4.74 (d, J = 5.6 Hz, 2H), 
2.56 (s, 6H), 1.43 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 155.99, 143.23, 141.64, 
141.03, 135.17, 132.53, 132.05, 131.42, 128.44, 127.11, 124.31, 122.23, 121.58, 
90.82, 88.87, 65.14, 14.82; EI-HRMS m/z calcd for C28H25BF2N2ONa [M + Na]+ 
477.1921, found 477.1925. 
BODIPY 8. A 100 mL round-bottom flask equipped with a magnetic stir bar 
was charged with 7 (260 mg, 0.57 mmol) and CH2Cl2 (50 mL). The resultant solution 
was cooled to 0 °C using an ice bath. Then DMF (0.5 mL) was added via syringe, 
followed by PBr3 (0.86 mL, 1.0 M in CH2Cl2). The mixture was allowed to warm to rt 
without removal of the ice bath, and then it was stirred at rt overnight. The solvent 
was removed in vacuum. The residue was dissolved in CH2Cl2 (10 mL); a white solid 
that formed was removed by filtration. Silica gel was added to the filtered solution, 
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and after solvent removal, the silica-bound product was purified in a column of 
silica gel using 5% then 40% ethyl acetate in hexanes as eluent. BODIPY 8 was 
obtained as an orange solid (256 mg, 0.49 mmol, 87%). FTIR (neat) 3119, 3066, 
3034, 2960, 2922, 2851, 2739, 2680, 2347, 2129, 1926, 1546, 1534, 1513, 1498.5, 
1460, 1437, 1410, 1363, 1307, 1189, 1154, 1110, 1077, 1051, 974, 818, 762, 703 
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.4 Hz, 2H), 
7.40 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 5.99 (s, 2H), 4.51 (s, 2H), 2.56 (s, 6H), 
1.43 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 156.02, 143.22, 140.97, 138.40, 135.36, 
132.58, 132.24, 131.42, 129.39, 128.48, 124.13, 123.18, 121.61, 90.44, 89.67, 33.10, 
14.83; EI-HRMS m/z calcd for C28H25BBrF2N2 [M + H]+ 517.1283, found 517.1262. 
Compound 4. A 50 mL round-bottom flask equipped with a magnetic stir bar 
was charged with 8 (291 mg, 0.56 mmol), THF (9.0 mL), and 1-methylimidazole (90 
μL, 1.12 mmol), in that order. The mixture was stirred at 50 °C overnight. Then the 
mixture was cooled to rt, and filtered in vacuo. The orange solid obtained was 
washed with Et2O (5 mL, 4) and dried under vacuum, to give imidazolium salt 4 as 
a bright orange solid (326 mg, 0.54 mmol, 97%). FTIR (neat) 3626, 3452, 3381, 
3143, 3028, 2975, 2919, 2860, 2727, 2374, 2347, 2217.5, 2035, 1908, 1625, 1616, 
1546, 1510, 1466, 1398, 1363, 1304, 1257, 1186, 1157, 1118.5, 1080, 1039, 971, 
833, 815, 765, 700 cm−1; 1H NMR (400 MHz, DMSO-d6) δ 9.24 (s, 1H), 7.81 (d, J = 8.0 
Hz, 2H), 7.73 (s, 2H), 7.66 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 8.0 
Hz, 2H), 6.21 (s, 2H), 5.48 (s, 2H), 3.87 (s, 3H), 2.46 (s, 6H), 1.39 (s, 6H); 13C NMR 
(125 MHz, DMSO-d6) δ 155.18, 142.59, 140.91, 136.86, 135.69, 134.49, 132.28, 
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131.99, 130.43, 128.66, 128.52, 124.09, 122.94, 122.41, 122.31, 121.54, 89.93, 
89.36, 51.41, 35.93, 14.24, 14.15; EI-HRMS m/z calcd for C32H30BF2N4 [M - Br]+ 
519.2518, found 519.2532. 
Compound 10. A 50 mL round-bottom flask equipped with a magnetic stir 
bar was charged with 914 (260 mg, 0.57 mmol) and CH2Cl2 (15 mL). The resultant 
solution was cooled to 0 °C using an ice bath. DMF (0.15 mL) was added via syringe, 
followed by PBr3 (0.63 mL, 1.0 M in CH2Cl2). The mixture was allowed to warm to rt 
without removal of the ice bath, and then it was stirred at rt overnight. The solvent 
was removed in vacuo. The residue was dissolved in ethyl acetate (20 mL) and 
water (20 mL). The aqueous layer was extracted with ethyl acetate (3). The 
combined organic layers were dried over MgSO4 and filtered, and the solvent was 
removed from the filtrate in vacuo to afford the crude product as an orange solid. 
Purification was done by column chromatography in silica gel using 20% ethyl 
acetate in hexanes as eluent. Compound 10 was obtained as a bright orange solid 
(106 mg, 0.25 mmol, 61%). FTIR (neat) 3101, 3039.5, 2978, 2963, 2927.5, 2863, 
2730, 2677, 2497, 2377, 2347, 2306, 2123, 1728, 1625, 1613.5, 1540, 1501.5, 1469, 
1437, 1407, 1366, 1304, 1263, 1180, 1151, 1048, 965, 809, 753, 709 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 7.50 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 5.98 (s, 2H), 4.82 
(d, J = 3.2 Hz, 2H), 2.56 (s, 6H), 1.39 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 155.88, 
143.22, 141.09, 139.26, 135.31, 131.50, 130.00, 128.68, 121.54, 32.80, 14.80, 14.68; 
EI-HRMS m/z calcd for C20H20BBrF2N2Na [M + Na]+ 439.0784, found 439.0767. 
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Compound 5. A 25 mL round-bottom flask equipped with a magnetic stir bar 
was charged with 10 (208 mg, 0.50 mmol), THF (8.0 mL), and 1-methylimidazole 
(80 μL, 1.00 mmol), in that order. The mixture was stirred at 50 °C overnight. Then 
the mixture was cooled to rt, and filtered in vacuum. The orange solid obtained was 
washed with Et2O (5 mL, 4) and dried under vacuum, to give imidazolium salt 5 as 
a bright orange solid (247 mg, 0.49 mmol, 99%). FTIR (neat) 3458, 3381, 3143, 
3095.5, 2983.5, 2922, 2374, 2344, 2026, 1622, 1546, 1501.5, 1463, 1410, 1369, 
1307, 1180, 1148, 1051, 974, 847, 803, 762, 730 cm−1; 1H NMR (400 MHz, DMSO-d6) 
δ 9.26 (s, 1H), 7.75 (s, 2H), 7.55 (d, J = 7.6 Hz, 2H), 7.46 (d, J = 7.2 Hz, 2H), 6.18 (s, 
2H), 5.55 (s, 2H), 3.89 (s, 3H), 2.45 (s, 6H), 1.31 (s, 6H); 13C NMR (100 MHz, DMSO-
d6) δ 155.06, 142.64, 141.21, 136.99, 136.03, 134.31, 130.59, 128.84, 128.52, 
124.25, 122.23, 121.49, 51.38, 35.97, 14.22, 14.08; EI-HRMS m/z calcd for 
C24H26BF2N4 [M - Br]+ 419.2219, found 419.2217.  
BODIPY 13. See the general procedure for the Pd/Cu coupling reaction. The 
materials used were BODIPY 612 (349 mg, 0.77 mmol), 4-ethynylbenzoic acid17 (170 
mg, 1.16 mmol), PdCl2(PPh3)2 (27.0 mg, 38.0 μmol), CuI (15.0 mg, 77.0 μmol), TEA 
(5.0 mL), and THF (15.0 mL) at rt overnight. The crude product (348 mg), 
pentafluorophenol (135 mg, 0.73 mmol), DMAP (5 mg, 0.04 mmol), and DCC (224 
mg, 1.08 mmol) were added to a 50 mL round-bottom flask equipped with a 
magnetic stir bar. CH2Cl2 (12 mL) was added via syringe, and the mixture was 
stirred overnight at rt. The solvent was removed in vacuo, and the residue was 
purified on a silica gel column using 5%, then 30% ethyl acetate in hexanes. 
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Pentafluorophenol ester 13 was obtained as an orange solid (316 mg, 0.50 mmol, 
65% over two steps). FTIR (neat) 3499, 3361, 3101, 2998, 2954, 2925, 2857, 2733, 
2668, 2462, 2347, 2220, 1761, 1540, 1513, 1463, 1404, 1372, 1298, 1236, 1186, 
1151, 1077, 1045, 974, 824, 709 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 8.0 
Hz, 2H), 7.72 (d, J = 8.4 Hz, 4H), 7.34 (d, J = 8.0 Hz, 2H), 6.01 (s, 2H), 2.57 (s, 6H), 1.44 
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 162.24, 156.13, 143.13, 140.67, 136.05, 132.76, 
132.18, 131.34, 130.93, 129.71, 128.64, 126.61, 123.45, 121.65, 93.04, 89.71, 14.82. 
The chemical shifts of the four different types of carbons on the C6F5 ring are not 
reported because the extensive one-bond and long-range 13C−19F couplings make 
the individual signals too weak and broad to interpret with any confidence. EI-
HRMS m/z calcd for C34H22BF7N2O2Na [M + Na]+ 657.1588, found 657.1561.  
Complex 12. Inside a nitrogen-filled glove box, a 10 mL round-bottom flask 
equipped with a magnetic stir bar was charged with 1418 (50 mg, 66 μmol). CH2Cl2 
(3 mL) was added and the flask was capped with a septum. The seal of the septum 
was reinforced with Teflon tape and the flask was taken out of the glove box. 
Hydrogen chloride was bubbled into the flask for 1 h. The HCl was generated by 
drop-wise addition of conc. H2SO4 to NH4Cl. Then the mixture was stirred 2 h at rt. 
The solvent was removed by rotary evaporation. Next, the flask was charged with 
BODIPY 13. Under a nitrogen atmosphere, DMF (2.5 mL) and Et3N (0.2 mL) were 
added, and the mixture was stirred at rt overnight. The solvent was removed in 
vacuum (using a Schlenk line with a dry ice trap, not by rotary evaporation) at 40 °C. 
The residue was dissolved in degassed CH2Cl2 and purified under ~ anaerobic 
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conditions23 in a silica gel column (Geduran, see General Methods). In ~ anaerobic 
chromatography, the column was packed under a stream of nitrogen, and the 
solvents used as eluents (diethyl ether and pentane) were degassed prior to use 
with a sparge of nitrogen for 30 min. The product was eluted under nitrogen and it 
was collected in a round-bottom flask previously purged with nitrogen and 
equipped with a magnetic stir bar and a nitrogen sparge. The eluant was removed 
using a Schlenk line with a dry ice trap (not by rotary evaporation). Unreacted 
BODIPY 13 was removed using 50% distilled Et2O in pentane, then pure Et2O was 
used to elute the desired product. Complex 12 was obtained as a dark brown solid 
(56 mg, 50 μmol, 77%). FTIR (neat) 3343, 2963, 2922, 2854, 2733, 2379.5, 2344, 
2321, 2049.5, 1979, 1946, 1923, 1840, 1554, 1475, 1440, 1398, 1378, 1310, 1263, 
1198, 1157, 1083, 983, 853 cm−1; 1H NMR (500 MHz, CD2Cl2) δ 16.40 (s, 1H), 7.76 
(br s, 2H),  7.69 (d, J = 6.8 Hz, 2H), 7.57 (d, J = 7.2 Hz, 3H), 7.33 (d, J = 6.8 Hz, 2H), 
7.16 (br s, 1H), 7.10 (br s, 1H), 7.08 (br s, 1H), 6.99−6.98 (m, 1H), 6.92 (d, J = 5.2 Hz, 
2H), 6.87 (d, J = 6.4 Hz, 1H), 6.035 (s, 2H), 4.94 (m, 1H), 4.68 (br s, 1H), 4.32 (t, J = 
8.8 Hz, 1H), 3.955 (dd, J1 = 6.4 Hz, J2 = 8.8 Hz, 2H), 3.68 (br s, 1H), 2.90−2.80 (br m, 
3H), 2.52 (s, 6H), 2.41 (br m, 15H), 1.45 (s, 6H), 1.28 (br d, J = 8.8 Hz, 6H); 13C NMR 
(125 MHz, CD2Cl2) δ 297.09, 216.07, 167.26, 156.23, 152.62, 145.47, 143.76, 141.46, 
139.88, 139.69, 135.80, 133.91, 132.98, 132.09, 131.66, 130.98, 130.54, 130.40, 
130.06, 128.94, 127.89, 126.72, 124.17, 122.91, 122.84, 121.84, 113.49, 91.40, 
90.19, 75.74, 64.25, 42.67, 21.50, 21.36, 14.85; MALDI-TOF MS (+eV) m/z calcd for 
C60H63BCl2F2N5O2Ru 1106.9, found 1106.5. 
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Spectroscopic Measurements. Absorption spectra were recorded on a 
Shimadzu UV-3101PC spectrophotometer. UV−vis spectra have 2 nm slit. The 
fluorescence emission spectra were obtained in a Perkin Elmer LS50B instrument, 
using dichloromethane solutions exposed to air with absorbance between 0.01 − 
0.06. Two emission spectra were recorded for each compound and the two quantum 
yields obtained were then averaged. All fluorescence spectra were corrected. 
Excitation was done at the corresponding max − 30 nm wavelength. Rhodamine 6G 
was used as the reference (ref = 0.95 in EtOH, exc = 488 nm). The fluorescence 
quantum yield of 12 was calculated from eq. 1. F denotes the integral of the 
corrected fluorescence spectrum, A is the absorbance at the excitation wavelength 
and n is the refractive index of the medium. 
                                                
                     
 
                       
                                     (4.1)  
ROMP of 1,5-cyclooctadiene.21 Dichloromethane-d2 was freeze/pump/ 
thawed three times. Cod was distilled over CaH2 immediately prior the 
polymerization reaction. As reported by Grubbs,21 we too found that aged cod gave 
considerably lower rates. 1H NMR spectra were collected at 500 MHz. Inside a glove 
box, an NMR tube with a septum/screw-cap (model 27093, Sigma-Aldrich) was 
charged with catalyst solution (0.40 µmol) and CD2Cl2 to give a total volume of 0.80 
mL. The solution was equilibrated at 30 °C in the NMR probe. The sample was then 
ejected from the NMR instrument to add cod (50 µL, 0.40 mmol) via syringe. A series 
of spectra were collected over an appropiate period of time. The degree of 
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conversion to polymer was determined by comparing the ratio of the integrals of the 
methylene protons in the starting material at δ 2.36 (m) with those in the product at 
δ 2.09 br (m), δ 2.04 (br m).  
Calculation of Diffusion Constants using FCS. FCS records the fluorescence 
fluctuations from a single light-emitting source in a small open volume and 
transforms the time traces into autocorrelation curves via the correlation analysis. 
The intensity of the autocorrelation as a function of lagtime (τ) can be expressed in 
terms of experimental parameters as: 
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where Veff  is volume, r0 is beam waist, z0 is beam height,  D is characteristic diffusion 
time, and <C> is analyte concentration. The experimental characteristic diffusion 
time can thus be obtained by fitting the autocorrelation curves with the above 
equation. Finally, the three-dimensional diffusion coefficient (D) can be calculated 
using the following equation:  
   
  
 
  
                                                                  (4.3) 
Optical Setup for FCS. FCS was performed using a home-built inverted 
confocal  microscope (Observer.D1, Zeiss). The light from a 532 nm laser (Verdi-6, 
Coherent Inc.) is collimated and expanded to overﬁll the back aperture of a 
microscope objective (Fluar, Zeiss:100×, NA = 1.3). The beam was circularly 
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polarized using a λ/4 waveplate (Newport). The laser power was attenuated to ~ 
150 nW using neutral density ﬁlters (Thorlabs). This power gives a signal to 
background ratio of ~ 10, yet ensured negligible heating of the sample. The focal 
plane of the objective is set to approximately ~ 6 μm inside the solution to avoid 
excessive scattered light from the glass−water interface. Polystyrene fluorospheres 
(100 nm in diameter, Molecular Probes) are used for alignment and calibration of 
the focal volume. The fluorescence is collected in the backward direction and 
redirected to a 50 μm pinhole (Thorlabs) before focusing onto an avalanche 
photodetector (SPCM-AQRH, Perkin-Elmer). 
Supporting Information. 1H and 13C NMR spectra of new compounds. 
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4.6. Experimental Contributions Section 
My contributions to the experimental work described in this chapter are the 
following: synthesis and characterization of the fluorescent catalyst, as well as 
measurement of its optical properties and catalytic activity. Lin-Yung Wang carried 
out the FCS experiments. E. Loïc Samuel made figure 4.1. 
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Figure S1.1. 1H NMR spectrum of 8 (400 MHz, CDCl3). 
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Figure S1.2. 13C NMR spectrum of 8 (100 MHz, CDCl3). 
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Figure S1.3. 1H NMR spectrum of 10 (400 MHz, CDCl3).  
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Figure S1.4. 13C NMR spectrum of 10 (100 MHz, CDCl3). 
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Figure S1.5.1H NMR spectrum of 1 (400 MHz, CDCl3). 
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Figure S1.6. 1H NMR spectrum of 12 (500 MHz, CDCl3).  
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Figure S1.7. 13C NMR spectrum of 12 (125 MHz, CDCl3). 
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Figure S1.8. 1H NMR spectrum of 14 (400 MHz, CDCl3). 
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Figure S1.9. 13C NMR spectrum of 14 (100 MHz, CDCl3). 
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Figure S1.10. 1H NMR spectrum of 16 (400 MHz, CDCl3). 
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Figure S1.11. 13C NMR spectrum of 16 (100 MHz, CDCl3). 
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Figure S1.12. 1H NMR spectrum of 17 (500 MHz, CDCl3). 
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Figure S1.13. 13C NMR spectrum of 17 (125 MHz, CDCl3). 
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Figure S1.14. 1H NMR spectrum of 19 (400 MHz, CDCl3). 
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Figure S1.15. 13C NMR spectrum of 19 (100 MHz, CDCl3). 
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Figure S1.16. 1H NMR spectrum of 20 (400 MHz, CDCl3). 
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Figure S1.17. 13C NMR spectrum of 20 (100 MHz, CDCl3). 
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Figure S1.18. 1H NMR spectrum of 21 (500 MHz, CDCl3). 
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Figure S1.19. 13C NMR spectrum of 21 (125 MHz, CDCl3). 
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Figure S1.20. 1H NMR spectrum of 2 (400 MHz, CDCl3). 
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Figure S1.21. 1H NMR spectrum of 23 (400 MHz, CDCl3). 
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Figure S1.22. 13C NMR spectrum of 23 (100 MHz, CDCl3). 
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Figure S1.23. 1H NMR spectrum of 24 (400 MHz, CDCl3). 
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Figure S1.24. 13C NMR spectrum of 24 (100 MHz, CDCl3). 
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Figure S1.25. 1H NMR spectrum of 25 (400 MHz, CDCl3). 
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Figure S1.26. 13C NMR spectrum of 25 (100 MHz, CDCl3). 
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Figure S1.27. 1H NMR spectrum of 26 (400 MHz, CDCl3). 
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Figure S1.28. 13C NMR spectrum of 26 (100 MHz, CDCl3). 
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Figure S1.29. 1H NMR spectrum of 3 (500 MHz, CDCl3). 
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Figure S1.30. 1H NMR spectrum of 29 (400 MHz, CDCl3). 
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Figure S1.31. 13C NMR spectrum of 29 (100 MHz, CDCl3). 
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Figure S1.32. 1H NMR spectrum of 30 (400 MHz, CDCl3). 
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Figure S1.33. 13C NMR spectrum of 30 (100 MHz, CDCl3).  
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Figure S1.34. 1H NMR spectrum of 31 (400 MHz, CDCl3). 
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Figure S1.35. 13C NMR spectrum of 31 (100 MHz, CDCl3). 
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Figure S1.36. 1H NMR spectrum of 32 (400 MHz, CDCl3). 
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Figure S1.37. 13C NMR spectrum of 32 (100 MHz, CDCl3). 
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Figure S1.38. 1H NMR spectrum of 4 (400 MHz, CDCl3). 
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Figure S1.39. 1H NMR spectrum of 34 (400 MHz, CDCl3). 
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Figure S1.40. 13C NMR spectrum of 34 (100 MHz, CDCl3). 
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Figure S1.41. 1H NMR spectrum of 35 (400 MHz, CDCl3). 
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Figure S1.42. 13C NMR spectrum of 35 (100 MHz, CDCl3).  
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Figure S1.43. 1H NMR spectrum of 5 (400 MHz, CDCl3). 
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NMR Spectra  
 
Figure S2.1. 1H NMR spectrum of 5 (400 MHz, CDCl3). 
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Figure S2.2. 1H NMR spectrum of 6 (400 MHz, CDCl3). 
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Figure S2.3. 13C NMR spectrum of 6 (100 MHz, CDCl3). 
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Figure S2.4. 1H NMR spectrum of 7 (400 MHz, CDCl3). 
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Figure S2.5. 13C NMR spectrum of 7 (125 MHz, CDCl3). 
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Figure S2.6. 1H NMR spectrum of 9 (400 MHz, CDCl3). 
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Figure S2.7. 13C NMR spectrum of 9 (100 MHz, CDCl3). 
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Figure S2.8. 1H NMR spectrum of 10 (400 MHz, CDCl3). 
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Figure S2.9. 13C NMR spectrum of 10 (125 MHz, CDCl3). 
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Figure S2.10. 1H NMR spectrum of 1 (400 MHz, CDCl3). 
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Figure S2.11. 13C NMR spectrum of 1 (100 MHz, CDCl3). 
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Figure S2.12. 1H NMR spectrum of 2 (400 MHz, CDCl3). 
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Figure S2.13. 13C NMR spectrum of 2 (125 MHz, CDCl3). 
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Figure S2.14. 1H NMR spectrum of 3 (400 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
S61 
 
Figure S2.15. 13C NMR spectrum of 3 (125 MHz, CDCl3). 
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Figure S2.16. 1H NMR spectrum of 13 (500 MHz, CDCl3). 
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Figure S2.17. 13C NMR spectrum of 13 (125 MHz, CDCl3). 
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Figure S2.18. 1H NMR spectrum of 14 (500 MHz, CDCl3). 
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Figure S2.19. 13C NMR spectrum of 14 (125 MHz, CDCl3). 
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Figure S2.20. 1H NMR spectrum of 4 (400 MHz, CDCl3). 
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Figure S2.21. 13C NMR spectrum of 4 (125 MHz, CDCl3). 
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Figure S2.22. 1H NMR spectrum of 15 (400 MHz, CDCl3). 
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Figure S2.23. 13C NMR spectrum of 15 (100 MHz, CDCl3). 
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Figure S2.24. 1H NMR spectrum of 16 (500 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S71 
 
Figure S2.25. 13C NMR spectrum of 16 (125 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time-lapse fluorescent images 
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Time-lapse fluorescence images 
         
 
  
Figure S2.26. Time-lapse fluorescence images showing the movement of a single 
BODIPY-based nanocar 2 on plasma cleaned glass. Each image is 2.4 x 2.4 m. 
 
 
 
 
S73 
 
AFM images of different substrates 
 
Figure S2.27. AFM images (1 μm x 1 μm) of plasma cleaned glass (A), etched glass 
(B), and VectabondTM treated glass (C). The insets show line scans taken on each 
surface. The average surface roughness of these surfaces was measured to be 0.4 ± 
0.1 nm (glass), 2.6 ± 0.2 nm (etched glass), and 0.5 ± 0.2 nm (VectabondTM treated 
glass). Surface holes (dark spots) are seen for VectabondTM treated surfaces, which 
are as big as 50 nm in diameter and 5 nm in height. They are most likely due to an 
uneven surface functionalization, but contribute at most 2-3 % to the total surface 
area. 
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Figure S3.1. 1H NMR spectrum of 3 (400 MHz, CDCl3). 
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Figure S3.2.13C NMR spectrum of 3 (125 MHz, CDCl3). 
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Figure S3.3. 1H NMR spectrum of 4 (500 MHz, CDCl3). 
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Figure S3.4. 13C NMR spectrum of 4 (125 MHz, CDCl3). 
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Figure S3.5. 1H NMR spectrum of 5 (500 MHz, CDCl3). 
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Figure S3.6. 13C NMR spectrum of 5 (125 MHz, CDCl3). 
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Figure S3.7. 1H NMR spectrum of 8 (500 MHz, CDCl3). 
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Figure S3.8. 13C NMR spectrum of 8 (125 MHz, CDCl3). 
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Figure S3.9. 1H NMR spectrum of 9 (400 MHz, CDCl3). 
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Figure S3.10. 13C NMR spectrum of 9 (125 MHz, CDCl3). 
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Figure S3.11. 1H NMR spectrum of 10 (500 MHz, CDCl3). 
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Figure S3.12. Amplification of 1H NMR spectrum of 10 (500 MHz, CDCl3). 
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Figure S3.13. 13C NMR spectrum of 10 (125 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S88 
 
Figure S3.14. 1H NMR spectrum of 1 (500 MHz, CDCl3). 
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Figure S3.15. Amplification of 1H NMR spectrum of 1 (500 MHz, CDCl3). 
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Figure S3.16. 13C NMR spectrum of 1 (125 MHz, CDCl3). 
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Figure S3.17. Amplification of 13C NMR spectrum of 1 (125 MHz, CDCl3). 
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Figure S3.18. 31P NMR spectrum of 1 (202 MHz, CDCl3). 
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Figure S3.19. 1H NMR spectrum of 2 (500 MHz, CDCl3). 
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Figure S3.20. Amplification of 1H NMR spectrum of 2 (500 MHz, CDCl3). 
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Figure S3.21. 13C NMR spectrum of 2 (125 MHz, CDCl3). 
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Figure S3.22. Amplification of 13C NMR spectrum of 2 (125 MHz, CDCl3). 
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ROMP of 1,5 cyclooctadiene 
Catalytic activity of 1. 102 µL of a 4.0 mM solution, 0.70 mL of CD2Cl2. 
Table S3.1. Conversion to polymer product using 1. 
Time (min) Conversion (%) 
3.8 
4.8 
5.8 
6.8 
7.8 
8.8 
9.8 
10.8 
11.8 
12.8 
13.8 
14.8 
15.8 
16.8 
17.8 
18.8 
19.8 
20.8 
21.8 
22.8 
1.9 
2.5 
2.5 
2.8 
3.1 
3.0 
3.3 
3.3 
3.6 
3.7 
3.6 
3.9 
3.7 
3.9 
4.0 
3.9 
4.1 
3.9 
4.3 
4.2 
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Time (min) Conversion (%) 
23.8 
24.8 
25.8 
26.8 
27.8 
28.8 
29.8 
30.8 
31.8 
32.8 
33.8 
34.8 
35.8 
36.8 
37.8 
38.8 
39.8 
40.8 
41.8 
42.8 
43.8 
44.8 
45.8 
46.8 
47.8 
4.0 
4.3 
4.3 
4.1 
4.4 
4.3 
4.4 
4.5 
4.3 
4.4 
4.5 
4.6 
4.6 
4.5 
4.6 
4.6 
4.8 
4.6 
4.6 
4.6 
4.7 
4.7 
4.9 
4.8 
5.0 
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Time (min) Conversion (%) 
48.8 
49.8 
50.8 
51.8 
52.8 
53.8 
54.8 
55.8 
56.8 
57.8 
58.8 
59.8 
60.8 
 
5.0 
4.9 
5.0 
5.0 
5.0 
5.1 
5.2 
5.0 
5.3 
5.1 
5.1 
5.3 
5.2 
 
Catalytic activity of 2. 120 µL of a 3.3 mM solution, 0.68 mL of CD2Cl2. 
Table S3.2. Conversion to polymer product using 2. 
Time (min) Conversion (%) 
3.0 99.4 
4.0 99.8 
5.0 99.9 
6.0 99.9 
7.0 100.0 
8.0 100.0 
9.0 100.0 
10.0 100.0 
11.0 99.9 
12.0 100.0 
13.0 100.0 
14.0 100.0 
15.0 100.0 
16.0 100.0 
17.0 100.0 
S100 
 
18.0 100.0 
 
In order to determine if our experimental setup was in good agreement with the standard 
system developed by Grubbs4 and therefore producing comparable results, we measured 
the activity of catalysts 11 and 12. 
 
 
Figure S3.23. Observed polymerization (exp.) versus previously reported data (lit). 
ROMP of norbornene with 1. A 3-neck 25 mL round-bottom flask equipped with a 
magnetic stir bar was charged with a solution of norbornene (35.3 mg, 0.37 mmol) in CH2Cl2 
(6 mL). Complex 1 (100 µL of a 3.75 mM solution, 0.37 µmol) was added in one portion and 
the mixture was stirred 10 min at rt. The solvent was evaporated. The polymer was washed 
with MeOH to afford ring-opened polynorbornene (32.0 mg, 91%).  
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A Polymerization-Propelled 
‘Nanosubmarine’: Synthesis and 
Diffusion Studies  
 
1H and 13C NMR spectra of new compounds 
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Figure S4.1. 1H NMR spectrum of 4-ethynyl benzyl alcohol (400 MHz, CDCl3). 
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Figure S4.2. 1H NMR spectrum of BODIPY 7 (400 MHz, CDCl3). 
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Figure S4.3. 13C NMR spectrum of BODIPY 7 (100 MHz, CDCl3). 
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Figure S4.4. 1H NMR spectrum of BODIPY 8 (400 MHz, CDCl3). 
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Figure S4.5. 13C NMR spectrum of BODIPY 8 (100 MHz, CDCl3). 
S107 
 
Figure S4.6. 1H NMR spectrum of 4 (400 MHz, DMSO-d6). 
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Figure S4.7. 13C NMR spectrum of 4 (125 MHz, DMSO-d6). 
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Figure S4.8. 1H NMR spectrum of BODIPY 10 (400 MHz, CDCl3). 
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Figure S4.9. 13C NMR spectrum of BODIPY 10 (100 MHz, CDCl3). 
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Figure S4.10. 1H NMR spectrum of 5 (400 MHz, DMSO-d6). 
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Figure S4.11. 13C NMR spectrum of 5 (100 MHz, DMSO-d6). 
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Figure S4.12. 1H NMR spectrum of 13 (400 MHz, CDCl3). 
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Figure S4.13. 13C NMR spectrum of 13 (125 MHz, CDCl3). 
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Figure S4.14. 1H NMR spectrum of 12 (500 MHz, CD2Cl2). 
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Figure S4.15. Amplification of 1 of 1H NMR spectrum of 12 (500 MHz, CD2Cl2). 
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Figure S4.16. Amplification 2 of 1H NMR spectrum of 12 (500 MHz, CD2Cl2). 
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Figure S4.17. 13C NMR spectrum of 12 (125 MHz, CD2Cl2). 
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Figure S4.18. Amplification of 13C NMR spectrum of 12 (125 MHz, CD2Cl2). 
